TWI605091B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents
Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDFInfo
- Publication number
- TWI605091B TWI605091B TW102131039A TW102131039A TWI605091B TW I605091 B TWI605091 B TW I605091B TW 102131039 A TW102131039 A TW 102131039A TW 102131039 A TW102131039 A TW 102131039A TW I605091 B TWI605091 B TW I605091B
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- group
- crystal alignment
- diamine
- alignment agent
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 169
- 239000003795 chemical substances by application Substances 0.000 title claims description 76
- -1 diamine compounds Chemical class 0.000 claims description 89
- 229920000642 polymer Polymers 0.000 claims description 67
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims description 46
- 150000004985 diamines Chemical class 0.000 claims description 46
- 239000002243 precursor Substances 0.000 claims description 28
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 238000000576 coating method Methods 0.000 claims description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 239000011248 coating agent Substances 0.000 claims description 15
- 125000001931 aliphatic group Chemical group 0.000 claims description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- 229920001721 polyimide Polymers 0.000 claims description 13
- 239000004642 Polyimide Substances 0.000 claims description 12
- 108010039918 Polylysine Proteins 0.000 claims description 10
- 229920000656 polylysine Polymers 0.000 claims description 10
- 125000004744 butyloxycarbonyl group Chemical group 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000004185 ester group Chemical group 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005245 sintering Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 2
- 239000010408 film Substances 0.000 description 68
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 46
- 239000000243 solution Substances 0.000 description 41
- 239000002904 solvent Substances 0.000 description 38
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 37
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 31
- 239000000758 substrate Substances 0.000 description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 25
- 150000001875 compounds Chemical class 0.000 description 25
- 239000000203 mixture Substances 0.000 description 25
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 22
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- 239000002253 acid Substances 0.000 description 18
- 239000003960 organic solvent Substances 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 238000005160 1H NMR spectroscopy Methods 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 12
- 210000002858 crystal cell Anatomy 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 229910001873 dinitrogen Inorganic materials 0.000 description 9
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 9
- 229920005575 poly(amic acid) Polymers 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 8
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000011259 mixed solution Substances 0.000 description 8
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 7
- 238000007664 blowing Methods 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 229910052731 fluorine Inorganic materials 0.000 description 7
- 229920000768 polyamine Polymers 0.000 description 7
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
- 206010047571 Visual impairment Diseases 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 4
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- LSKONYYRONEBKA-UHFFFAOYSA-N 2-Dodecanone Chemical compound CCCCCCCCCCC(C)=O LSKONYYRONEBKA-UHFFFAOYSA-N 0.000 description 4
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 4
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 4
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 4
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 4
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 4
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 4
- WVOLTBSCXRRQFR-DLBZAZTESA-M cannabidiolate Chemical compound OC1=C(C([O-])=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-M 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000012456 homogeneous solution Substances 0.000 description 4
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 4
- 108010026466 polyproline Proteins 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- RSPCKAHMRANGJZ-UHFFFAOYSA-N thiohydroxylamine Chemical group SN RSPCKAHMRANGJZ-UHFFFAOYSA-N 0.000 description 4
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 4
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 3
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- XYSNGNNDJGSUMY-UHFFFAOYSA-N C(C1CO1)OCCCC(C(OCC)(OCC)C)CCCCCCCC Chemical compound C(C1CO1)OCCCC(C(OCC)(OCC)C)CCCCCCCC XYSNGNNDJGSUMY-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- AMNPXXIGUOKIPP-UHFFFAOYSA-N [4-(carbamothioylamino)phenyl]thiourea Chemical compound NC(=S)NC1=CC=C(NC(N)=S)C=C1 AMNPXXIGUOKIPP-UHFFFAOYSA-N 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 3
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 108010094020 polyglycine Proteins 0.000 description 3
- 229920000232 polyglycine polymer Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000565 sealant Substances 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- RYNQKSJRFHJZTK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) acetate Chemical compound COC(C)(C)CCOC(C)=O RYNQKSJRFHJZTK-UHFFFAOYSA-N 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- JDGFELYPUWNNGR-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene-1,3,4,6-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C2C(C(=O)O)CC(C(O)=O)C21 JDGFELYPUWNNGR-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- COLYDFXUNAQRBZ-UHFFFAOYSA-N 1-(1-ethoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCOCC(C)OCC(C)OC(C)=O COLYDFXUNAQRBZ-UHFFFAOYSA-N 0.000 description 2
- LAVARTIQQDZFNT-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-yl acetate Chemical compound COCC(C)OCC(C)OC(C)=O LAVARTIQQDZFNT-UHFFFAOYSA-N 0.000 description 2
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 2
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 2
- ONDSSKDTLGWNOJ-UHFFFAOYSA-N 1-methoxyhexan-2-ol Chemical compound CCCCC(O)COC ONDSSKDTLGWNOJ-UHFFFAOYSA-N 0.000 description 2
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 2
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 2
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 2
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 2
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 2
- PPPFYBPQAPISCT-UHFFFAOYSA-N 2-hydroxypropyl acetate Chemical compound CC(O)COC(C)=O PPPFYBPQAPISCT-UHFFFAOYSA-N 0.000 description 2
- HCGFUIQPSOCUHI-UHFFFAOYSA-N 2-propan-2-yloxyethanol Chemical compound CC(C)OCCO HCGFUIQPSOCUHI-UHFFFAOYSA-N 0.000 description 2
- LJGHYPLBDBRCRZ-UHFFFAOYSA-N 3-(3-aminophenyl)sulfonylaniline Chemical group NC1=CC=CC(S(=O)(=O)C=2C=C(N)C=CC=2)=C1 LJGHYPLBDBRCRZ-UHFFFAOYSA-N 0.000 description 2
- JRXXEXVXTFEBIY-UHFFFAOYSA-N 3-ethoxypropanoic acid Chemical compound CCOCCC(O)=O JRXXEXVXTFEBIY-UHFFFAOYSA-N 0.000 description 2
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 2
- HTNUUDFQRYBJPH-UHFFFAOYSA-N 3-methoxypropanehydrazide Chemical compound COCCC(=O)NN HTNUUDFQRYBJPH-UHFFFAOYSA-N 0.000 description 2
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 2
- LJMPOXUWPWEILS-UHFFFAOYSA-N 3a,4,4a,7a,8,8a-hexahydrofuro[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1C2C(=O)OC(=O)C2CC2C(=O)OC(=O)C21 LJMPOXUWPWEILS-UHFFFAOYSA-N 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- WUPRYUDHUFLKFL-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(OC=2C=CC(N)=CC=2)=C1 WUPRYUDHUFLKFL-UHFFFAOYSA-N 0.000 description 2
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 2
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 2
- XJDCHDFUMGSEHD-UHFFFAOYSA-N NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCCC(C(OC)(OC)OC)CCCCCCCC XJDCHDFUMGSEHD-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920000037 Polyproline Polymers 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 229940072049 amyl acetate Drugs 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 2
- IJUHLFUALMUWOM-UHFFFAOYSA-N ethyl 3-methoxypropanoate Chemical compound CCOC(=O)CCOC IJUHLFUALMUWOM-UHFFFAOYSA-N 0.000 description 2
- 229940117360 ethyl pyruvate Drugs 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 229940018564 m-phenylenediamine Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 2
- 229940057867 methyl lactate Drugs 0.000 description 2
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- WSKHYOXDVZCOJP-UHFFFAOYSA-N naphthalene-1,6-diamine Chemical compound NC1=CC=CC2=CC(N)=CC=C21 WSKHYOXDVZCOJP-UHFFFAOYSA-N 0.000 description 2
- ZDWYJINCYGEEJB-UHFFFAOYSA-N naphthalene-1,7-diamine Chemical compound C1=CC=C(N)C2=CC(N)=CC=C21 ZDWYJINCYGEEJB-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 238000006068 polycondensation reaction Methods 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 150000004060 quinone imines Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 238000012916 structural analysis Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- 238000012982 x-ray structure analysis Methods 0.000 description 2
- FADNCTVVKDWKIX-UHFFFAOYSA-N (2,4-diaminophenyl)methanol Chemical compound NC1=CC=C(CO)C(N)=C1 FADNCTVVKDWKIX-UHFFFAOYSA-N 0.000 description 1
- LYSJSRSBKUIFDF-UHFFFAOYSA-N (2-aminophenyl)-(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C(=CC=CC=2)N)=C1 LYSJSRSBKUIFDF-UHFFFAOYSA-N 0.000 description 1
- OHLQBRYVKXJYHZ-UHFFFAOYSA-N (3,5-diaminophenyl)methanol Chemical compound NC1=CC(N)=CC(CO)=C1 OHLQBRYVKXJYHZ-UHFFFAOYSA-N 0.000 description 1
- YKNMIGJJXKBHJE-UHFFFAOYSA-N (3-aminophenyl)-(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=CC(N)=C1 YKNMIGJJXKBHJE-UHFFFAOYSA-N 0.000 description 1
- OLQWMCSSZKNOLQ-ZXZARUISSA-N (3s)-3-[(3r)-2,5-dioxooxolan-3-yl]oxolane-2,5-dione Chemical compound O=C1OC(=O)C[C@H]1[C@@H]1C(=O)OC(=O)C1 OLQWMCSSZKNOLQ-ZXZARUISSA-N 0.000 description 1
- UBHDUFNPQJWPRQ-UHFFFAOYSA-N (5-methyl-1h-imidazol-3-ium-4-yl)methanol;chloride Chemical compound Cl.CC=1NC=NC=1CO UBHDUFNPQJWPRQ-UHFFFAOYSA-N 0.000 description 1
- MQQRFOXFIPBFOV-UHFFFAOYSA-N 1,2-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C(O)=O)C1(C)C(O)=O MQQRFOXFIPBFOV-UHFFFAOYSA-N 0.000 description 1
- OURODNXVJUWPMZ-UHFFFAOYSA-N 1,2-diphenylanthracene Chemical compound C1=CC=CC=C1C1=CC=C(C=C2C(C=CC=C2)=C2)C2=C1C1=CC=CC=C1 OURODNXVJUWPMZ-UHFFFAOYSA-N 0.000 description 1
- VIESAWGOYVNHLV-UHFFFAOYSA-N 1,3-dihydropyrrol-2-one Chemical compound O=C1CC=CN1 VIESAWGOYVNHLV-UHFFFAOYSA-N 0.000 description 1
- SBHHKGFHJWTZJN-UHFFFAOYSA-N 1,3-dimethylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1(C)C(C(O)=O)C(C)(C(O)=O)C1C(O)=O SBHHKGFHJWTZJN-UHFFFAOYSA-N 0.000 description 1
- ULAFJDYDLJSYLI-UHFFFAOYSA-N 1,3-diphenylcyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound C1(=CC=CC=C1)C1(C(C(C1C(=O)O)(C(=O)O)C1=CC=CC=C1)C(=O)O)C(=O)O ULAFJDYDLJSYLI-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- YFOOEYJGMMJJLS-UHFFFAOYSA-N 1,8-diaminonaphthalene Chemical compound C1=CC(N)=C2C(N)=CC=CC2=C1 YFOOEYJGMMJJLS-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- PNBCGVPSRHMZDO-UHFFFAOYSA-N 1-(1-propoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCCOCC(C)OCC(C)OC(C)=O PNBCGVPSRHMZDO-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- HASUCEDGKYJBDC-UHFFFAOYSA-N 1-[3-[[bis(oxiran-2-ylmethyl)amino]methyl]cyclohexyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CC(CN(CC2OC2)CC2OC2)CCC1)CC1CO1 HASUCEDGKYJBDC-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RQUBQBFVDOLUKC-UHFFFAOYSA-N 1-ethoxy-2-methylpropane Chemical compound CCOCC(C)C RQUBQBFVDOLUKC-UHFFFAOYSA-N 0.000 description 1
- PZHIWRCQKBBTOW-UHFFFAOYSA-N 1-ethoxybutane Chemical compound CCCCOCC PZHIWRCQKBBTOW-UHFFFAOYSA-N 0.000 description 1
- PXFIPIAXFGAEMJ-UHFFFAOYSA-N 1-fluoro-2-(2-fluorophenyl)benzene Chemical group FC1=CC=CC=C1C1=CC=CC=C1F PXFIPIAXFGAEMJ-UHFFFAOYSA-N 0.000 description 1
- ULAJXVNCPQIRQD-UHFFFAOYSA-N 1-n,4-n-bis(3-aminophenyl)benzene-1,4-dicarboxamide Chemical compound NC1=CC=CC(NC(=O)C=2C=CC(=CC=2)C(=O)NC=2C=C(N)C=CC=2)=C1 ULAJXVNCPQIRQD-UHFFFAOYSA-N 0.000 description 1
- RPOHXHHHVSGUMN-UHFFFAOYSA-N 1-n,4-n-bis(4-aminophenyl)benzene-1,4-dicarboxamide Chemical compound C1=CC(N)=CC=C1NC(=O)C1=CC=C(C(=O)NC=2C=CC(N)=CC=2)C=C1 RPOHXHHHVSGUMN-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- IANXAXNUNBAWBA-UHFFFAOYSA-N 2,2,3-trimethylundecane Chemical compound CCCCCCCCC(C)C(C)(C)C IANXAXNUNBAWBA-UHFFFAOYSA-N 0.000 description 1
- CASXWXSTPJILAM-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-indene-1,3,4,6-tetracarboxylic acid Chemical compound C1C(C(O)=O)CC(C(O)=O)C2C1C(C(=O)O)CC2C(O)=O CASXWXSTPJILAM-UHFFFAOYSA-N 0.000 description 1
- WCZNKVPCIFMXEQ-UHFFFAOYSA-N 2,3,5,6-tetramethylbenzene-1,4-diamine Chemical compound CC1=C(C)C(N)=C(C)C(C)=C1N WCZNKVPCIFMXEQ-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- XQRUEDXXCQDNOT-UHFFFAOYSA-N 2,5-diaminophenol Chemical compound NC1=CC=C(N)C(O)=C1 XQRUEDXXCQDNOT-UHFFFAOYSA-N 0.000 description 1
- 229940075142 2,5-diaminotoluene Drugs 0.000 description 1
- BWAPJIHJXDYDPW-UHFFFAOYSA-N 2,5-dimethyl-p-phenylenediamine Chemical compound CC1=CC(N)=C(C)C=C1N BWAPJIHJXDYDPW-UHFFFAOYSA-N 0.000 description 1
- RLYCRLGLCUXUPO-UHFFFAOYSA-N 2,6-diaminotoluene Chemical compound CC1=C(N)C=CC=C1N RLYCRLGLCUXUPO-UHFFFAOYSA-N 0.000 description 1
- YXOGWQMEEWZLTB-UHFFFAOYSA-N 2,8-dihydroxy-2,4,6,8-tetramethylnonan-5-one Chemical class OC(CC(C)C(=O)C(C)CC(C)(O)C)(C)C YXOGWQMEEWZLTB-UHFFFAOYSA-N 0.000 description 1
- HOLGXWDGCVTMTB-UHFFFAOYSA-N 2-(2-aminophenyl)aniline Chemical group NC1=CC=CC=C1C1=CC=CC=C1N HOLGXWDGCVTMTB-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- CRQBUNFZJOLMKC-UHFFFAOYSA-N 2-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C(=CC=CC=2)N)=C1 CRQBUNFZJOLMKC-UHFFFAOYSA-N 0.000 description 1
- OHKOAJUTRVTYSW-UHFFFAOYSA-N 2-[(2-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC=C1CC1=CC=CC=C1N OHKOAJUTRVTYSW-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- ZGDMDBHLKNQPSD-UHFFFAOYSA-N 2-amino-5-(4-amino-3-hydroxyphenyl)phenol Chemical group C1=C(O)C(N)=CC=C1C1=CC=C(N)C(O)=C1 ZGDMDBHLKNQPSD-UHFFFAOYSA-N 0.000 description 1
- FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
- OBCSAIDCZQSFQH-UHFFFAOYSA-N 2-methyl-1,4-phenylenediamine Chemical compound CC1=CC(N)=CC=C1N OBCSAIDCZQSFQH-UHFFFAOYSA-N 0.000 description 1
- JRBJSXQPQWSCCF-UHFFFAOYSA-N 3,3'-Dimethoxybenzidine Chemical group C1=C(N)C(OC)=CC(C=2C=C(OC)C(N)=CC=2)=C1 JRBJSXQPQWSCCF-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical group C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- NEJLUYQBZMHTFW-UHFFFAOYSA-N 3,4-dimethoxy-4-(1,3,5-triazin-2-ylmethyl)morpholin-4-ium Chemical compound COC1[N+](CCOC1)(CC1=NC=NC=N1)OC NEJLUYQBZMHTFW-UHFFFAOYSA-N 0.000 description 1
- LXJLFVRAWOOQDR-UHFFFAOYSA-N 3-(3-aminophenoxy)aniline Chemical compound NC1=CC=CC(OC=2C=C(N)C=CC=2)=C1 LXJLFVRAWOOQDR-UHFFFAOYSA-N 0.000 description 1
- NDXGRHCEHPFUSU-UHFFFAOYSA-N 3-(3-aminophenyl)aniline Chemical group NC1=CC=CC(C=2C=C(N)C=CC=2)=C1 NDXGRHCEHPFUSU-UHFFFAOYSA-N 0.000 description 1
- ZBMISJGHVWNWTE-UHFFFAOYSA-N 3-(4-aminophenoxy)aniline Chemical compound C1=CC(N)=CC=C1OC1=CC=CC(N)=C1 ZBMISJGHVWNWTE-UHFFFAOYSA-N 0.000 description 1
- QSPMTSAELLSLOQ-UHFFFAOYSA-N 3-(4-aminophenyl)aniline Chemical group C1=CC(N)=CC=C1C1=CC=CC(N)=C1 QSPMTSAELLSLOQ-UHFFFAOYSA-N 0.000 description 1
- RHRNYXVSZLSRRP-UHFFFAOYSA-N 3-(carboxymethyl)cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CC1C(C(O)=O)CC(C(O)=O)C1C(O)=O RHRNYXVSZLSRRP-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- CKOFBUUFHALZGK-UHFFFAOYSA-N 3-[(3-aminophenyl)methyl]aniline Chemical compound NC1=CC=CC(CC=2C=C(N)C=CC=2)=C1 CKOFBUUFHALZGK-UHFFFAOYSA-N 0.000 description 1
- FGWQCROGAHMWSU-UHFFFAOYSA-N 3-[(4-aminophenyl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CC1=CC=CC(N)=C1 FGWQCROGAHMWSU-UHFFFAOYSA-N 0.000 description 1
- OQOCRVBUYRQQPS-UHFFFAOYSA-N 3-[2-(3-aminophenyl)ethyl]aniline Chemical compound NC1=CC=CC(CCC=2C=C(N)C=CC=2)=C1 OQOCRVBUYRQQPS-UHFFFAOYSA-N 0.000 description 1
- LMQOEUTZXKKSBC-UHFFFAOYSA-N 3-[3-(3-aminophenoxy)propoxy]aniline Chemical compound NC1=CC=CC(OCCCOC=2C=C(N)C=CC=2)=C1 LMQOEUTZXKKSBC-UHFFFAOYSA-N 0.000 description 1
- CKTOHFTWIAKLPM-UHFFFAOYSA-N 3-[3-(3-aminophenyl)propyl]aniline Chemical compound NC1=CC=CC(CCCC=2C=C(N)C=CC=2)=C1 CKTOHFTWIAKLPM-UHFFFAOYSA-N 0.000 description 1
- ITXOUPUVWUUSAN-UHFFFAOYSA-N 3-[4-(3-aminophenyl)butyl]aniline Chemical compound NC=1C=C(C=CC1)CCCCC1=CC(=CC=C1)N ITXOUPUVWUUSAN-UHFFFAOYSA-N 0.000 description 1
- XKBRJCSVQIUYGX-UHFFFAOYSA-N 3-[5-(3-aminophenoxy)pentoxy]aniline Chemical compound NC1=CC=CC(OCCCCCOC=2C=C(N)C=CC=2)=C1 XKBRJCSVQIUYGX-UHFFFAOYSA-N 0.000 description 1
- VUGSDMVMFIXNFG-UHFFFAOYSA-N 3-amino-n-[3-[(3-aminobenzoyl)amino]phenyl]benzamide Chemical compound NC1=CC=CC(C(=O)NC=2C=C(NC(=O)C=3C=C(N)C=CC=3)C=CC=2)=C1 VUGSDMVMFIXNFG-UHFFFAOYSA-N 0.000 description 1
- DHUWREIRBJAQAT-UHFFFAOYSA-N 3-amino-n-[4-[(3-aminobenzoyl)amino]phenyl]benzamide Chemical compound NC1=CC=CC(C(=O)NC=2C=CC(NC(=O)C=3C=C(N)C=CC=3)=CC=2)=C1 DHUWREIRBJAQAT-UHFFFAOYSA-N 0.000 description 1
- XFDUHJPVQKIXHO-UHFFFAOYSA-M 3-aminobenzoate Chemical compound NC1=CC=CC(C([O-])=O)=C1 XFDUHJPVQKIXHO-UHFFFAOYSA-M 0.000 description 1
- CRORGGSWAKIXSA-UHFFFAOYSA-N 3-methylbutyl 2-hydroxypropanoate Chemical compound CC(C)CCOC(=O)C(C)O CRORGGSWAKIXSA-UHFFFAOYSA-N 0.000 description 1
- XTEBLARUAVEBRF-UHFFFAOYSA-N 4-(1,1,1,3,3,3-hexafluoropropan-2-yl)aniline Chemical compound NC1=CC=C(C(C(F)(F)F)C(F)(F)F)C=C1 XTEBLARUAVEBRF-UHFFFAOYSA-N 0.000 description 1
- FFKSVVOWOROQIU-UHFFFAOYSA-N 4-(2,5-dioxooxolan-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic acid Chemical compound C12=CC=CC=C2C(C(O)=O)C(C(=O)O)CC1C1CC(=O)OC1=O FFKSVVOWOROQIU-UHFFFAOYSA-N 0.000 description 1
- AIVVXPSKEVWKMY-UHFFFAOYSA-N 4-(3,4-dicarboxyphenoxy)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1OC1=CC=C(C(O)=O)C(C(O)=O)=C1 AIVVXPSKEVWKMY-UHFFFAOYSA-N 0.000 description 1
- XDYLWBWPEDSSLU-UHFFFAOYSA-N 4-(3-carboxyphenyl)benzene-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC(C=2C(=C(C(O)=O)C(C(O)=O)=CC=2)C(O)=O)=C1 XDYLWBWPEDSSLU-UHFFFAOYSA-N 0.000 description 1
- BMTZEAOGFDXDAD-UHFFFAOYSA-M 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 BMTZEAOGFDXDAD-UHFFFAOYSA-M 0.000 description 1
- KHYXYOGWAIYVBD-UHFFFAOYSA-N 4-(4-propylphenoxy)aniline Chemical compound C1=CC(CCC)=CC=C1OC1=CC=C(N)C=C1 KHYXYOGWAIYVBD-UHFFFAOYSA-N 0.000 description 1
- SXPGQGNWEWPWQZ-UHFFFAOYSA-N 4-(triethoxymethyl)dodecan-1-amine Chemical compound NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SXPGQGNWEWPWQZ-UHFFFAOYSA-N 0.000 description 1
- GNPSQUCXOBDIDY-UHFFFAOYSA-N 4-(trimethoxymethyl)dodecane Chemical compound C(CCCCCCC)C(C(OC)(OC)OC)CCC GNPSQUCXOBDIDY-UHFFFAOYSA-N 0.000 description 1
- QIKYZXDTTPVVAC-UHFFFAOYSA-N 4-Aminobenzamide Chemical compound NC(=O)C1=CC=C(N)C=C1 QIKYZXDTTPVVAC-UHFFFAOYSA-N 0.000 description 1
- IWXCYYWDGDDPAC-UHFFFAOYSA-N 4-[(3,4-dicarboxyphenyl)methyl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1CC1=CC=C(C(O)=O)C(C(O)=O)=C1 IWXCYYWDGDDPAC-UHFFFAOYSA-N 0.000 description 1
- IGSBHTZEJMPDSZ-UHFFFAOYSA-N 4-[(4-amino-3-methylcyclohexyl)methyl]-2-methylcyclohexan-1-amine Chemical compound C1CC(N)C(C)CC1CC1CC(C)C(N)CC1 IGSBHTZEJMPDSZ-UHFFFAOYSA-N 0.000 description 1
- DZIHTWJGPDVSGE-UHFFFAOYSA-N 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CC(N)CCC1CC1CCC(N)CC1 DZIHTWJGPDVSGE-UHFFFAOYSA-N 0.000 description 1
- DODZITHJXOKQAB-UHFFFAOYSA-N 4-[1-(4-aminophenyl)decyl]aniline Chemical compound C=1C=C(N)C=CC=1C(CCCCCCCCC)C1=CC=C(N)C=C1 DODZITHJXOKQAB-UHFFFAOYSA-N 0.000 description 1
- ASNOFHCTUSIHOM-UHFFFAOYSA-N 4-[10-(4-aminophenyl)anthracen-9-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=C(N)C=C1 ASNOFHCTUSIHOM-UHFFFAOYSA-N 0.000 description 1
- APXJLYIVOFARRM-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(C(O)=O)C(C(O)=O)=C1 APXJLYIVOFARRM-UHFFFAOYSA-N 0.000 description 1
- GEYAGBVEAJGCFB-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)propan-2-yl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1C(C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 GEYAGBVEAJGCFB-UHFFFAOYSA-N 0.000 description 1
- KWFFEQXPFFDJER-UHFFFAOYSA-N 4-[3-(4-aminophenoxy)propoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCOC1=CC=C(N)C=C1 KWFFEQXPFFDJER-UHFFFAOYSA-N 0.000 description 1
- BOVVHULZWVFIOX-UHFFFAOYSA-N 4-[3-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=CC(C=2C=CC(N)=CC=2)=C1 BOVVHULZWVFIOX-UHFFFAOYSA-N 0.000 description 1
- BMIUMBLWVWZIHD-UHFFFAOYSA-N 4-[3-(4-aminophenyl)propyl]aniline Chemical compound C1=CC(N)=CC=C1CCCC1=CC=C(N)C=C1 BMIUMBLWVWZIHD-UHFFFAOYSA-N 0.000 description 1
- LAFZPVANKKJENB-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)butoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCOC1=CC=C(N)C=C1 LAFZPVANKKJENB-UHFFFAOYSA-N 0.000 description 1
- JCRRFJIVUPSNTA-UHFFFAOYSA-N 4-[4-(4-aminophenoxy)phenoxy]aniline Chemical compound C1=CC(N)=CC=C1OC(C=C1)=CC=C1OC1=CC=C(N)C=C1 JCRRFJIVUPSNTA-UHFFFAOYSA-N 0.000 description 1
- PZBWQICCJHUJGP-UHFFFAOYSA-N 4-[4-(4-aminophenyl)butyl]aniline Chemical compound C1=CC(N)=CC=C1CCCCC1=CC=C(N)C=C1 PZBWQICCJHUJGP-UHFFFAOYSA-N 0.000 description 1
- QBSMHWVGUPQNJJ-UHFFFAOYSA-N 4-[4-(4-aminophenyl)phenyl]aniline Chemical compound C1=CC(N)=CC=C1C1=CC=C(C=2C=CC(N)=CC=2)C=C1 QBSMHWVGUPQNJJ-UHFFFAOYSA-N 0.000 description 1
- SLHXQWDUYXSTPA-UHFFFAOYSA-N 4-[5-(4-aminophenoxy)pentoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCOC1=CC=C(N)C=C1 SLHXQWDUYXSTPA-UHFFFAOYSA-N 0.000 description 1
- UURATDYSEHCBAO-UHFFFAOYSA-N 4-[6-(3,4-dicarboxyphenyl)pyridin-2-yl]phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=CC(C=2C=C(C(C(O)=O)=CC=2)C(O)=O)=N1 UURATDYSEHCBAO-UHFFFAOYSA-N 0.000 description 1
- GRFCDFDVGOXFPY-UHFFFAOYSA-N 4-[6-(4-aminophenoxy)hexoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCOC1=CC=C(N)C=C1 GRFCDFDVGOXFPY-UHFFFAOYSA-N 0.000 description 1
- JBXBSFFXAMVASC-UHFFFAOYSA-N 4-[7-(4-aminophenoxy)heptoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCOC1=CC=C(N)C=C1 JBXBSFFXAMVASC-UHFFFAOYSA-N 0.000 description 1
- SURHEQARWKWZMT-UHFFFAOYSA-N 4-[8-(4-aminophenoxy)octoxy]aniline Chemical compound C1=CC(N)=CC=C1OCCCCCCCCOC1=CC=C(N)C=C1 SURHEQARWKWZMT-UHFFFAOYSA-N 0.000 description 1
- LGTGOCSQAOUUFP-UHFFFAOYSA-N 4-amino-n-[4-[(4-aminobenzoyl)amino]phenyl]benzamide Chemical compound C1=CC(N)=CC=C1C(=O)NC(C=C1)=CC=C1NC(=O)C1=CC=C(N)C=C1 LGTGOCSQAOUUFP-UHFFFAOYSA-N 0.000 description 1
- HRXZRAXKKNUKRF-UHFFFAOYSA-N 4-ethylaniline Chemical compound CCC1=CC=C(N)C=C1 HRXZRAXKKNUKRF-UHFFFAOYSA-N 0.000 description 1
- DNGJVDGPCGXBFF-UHFFFAOYSA-N 4-methyl-n-(methyldiazenyl)aniline Chemical compound CN=NNC1=CC=C(C)C=C1 DNGJVDGPCGXBFF-UHFFFAOYSA-N 0.000 description 1
- IWQQNPRIJQLWFE-UHFFFAOYSA-N 4-methyl-n-(propyldiazenyl)aniline Chemical compound CCCN=NNC1=CC=C(C)C=C1 IWQQNPRIJQLWFE-UHFFFAOYSA-N 0.000 description 1
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 description 1
- QZHXKQKKEBXYRG-UHFFFAOYSA-N 4-n-(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NC1=CC=C(N)C=C1 QZHXKQKKEBXYRG-UHFFFAOYSA-N 0.000 description 1
- VQVIHDPBMFABCQ-UHFFFAOYSA-N 5-(1,3-dioxo-2-benzofuran-5-carbonyl)-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)=O)=C1 VQVIHDPBMFABCQ-UHFFFAOYSA-N 0.000 description 1
- 101100316860 Autographa californica nuclear polyhedrosis virus DA18 gene Proteins 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- MSMWHDLMOOPUDG-UHFFFAOYSA-N C(=O)(O)C=1C=C(C=CC1C(=O)O)C(C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC(=C(C=C1)C(=O)O)C(=O)O)CCCCCCCC Chemical compound C(=O)(O)C=1C=C(C=CC1C(=O)O)C(C(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC(=C(C=C1)C(=O)O)C(=O)O)CCCCCCCC MSMWHDLMOOPUDG-UHFFFAOYSA-N 0.000 description 1
- OTQABGJKDOUMOB-UHFFFAOYSA-N C(=O)(O)C=1C=C(C=CC1C(=O)O)C(CCCC(CCCC)(C)C)C1=CC(=C(C=C1)C(=O)O)C(=O)O Chemical compound C(=O)(O)C=1C=C(C=CC1C(=O)O)C(CCCC(CCCC)(C)C)C1=CC(=C(C=C1)C(=O)O)C(=O)O OTQABGJKDOUMOB-UHFFFAOYSA-N 0.000 description 1
- JGFGMVAAQJDHFG-UHFFFAOYSA-N C(C)(=O)OCCNCCNCCC(C)CCCCCCCCCC(OCC)(OCC)OCC Chemical compound C(C)(=O)OCCNCCNCCC(C)CCCCCCCCCC(OCC)(OCC)OCC JGFGMVAAQJDHFG-UHFFFAOYSA-N 0.000 description 1
- OTXFGEHSBKFEAB-UHFFFAOYSA-N C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C)OC(=O)NCCCC(C(OC)(OC)OC)CCCCCCCC OTXFGEHSBKFEAB-UHFFFAOYSA-N 0.000 description 1
- ICWNIKLKVHTFOW-UHFFFAOYSA-N C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC Chemical compound C(C)OC(CCCCCCCCCCCCNCCNCCN)(OCC)OCC ICWNIKLKVHTFOW-UHFFFAOYSA-N 0.000 description 1
- PXUZMWOTICHNDV-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OC)(OC)OC)CCCCCCCC PXUZMWOTICHNDV-UHFFFAOYSA-N 0.000 description 1
- SNPIERCLNKIBEM-UHFFFAOYSA-N C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(C1=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC SNPIERCLNKIBEM-UHFFFAOYSA-N 0.000 description 1
- YZNMEBHHGSMZHS-UHFFFAOYSA-N C(C=C)(=O)OCCCC.COCCC Chemical compound C(C=C)(=O)OCCCC.COCCC YZNMEBHHGSMZHS-UHFFFAOYSA-N 0.000 description 1
- XRNDMACZMJPCRX-UHFFFAOYSA-N C(CC)C(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C(CC)C(C(OCC)(OCC)OCC)CCCCCCCC XRNDMACZMJPCRX-UHFFFAOYSA-N 0.000 description 1
- YDEAAJZYBOCXIO-UHFFFAOYSA-N C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound C1(=CC=CC=C1)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC YDEAAJZYBOCXIO-UHFFFAOYSA-N 0.000 description 1
- DFRIXUYMTXMYAA-UHFFFAOYSA-N C=1(C(=CC=C2C3=C(C(=CC=C3CC12)C(=O)O)C(=O)O)C(=O)O)C(=O)O Chemical compound C=1(C(=CC=C2C3=C(C(=CC=C3CC12)C(=O)O)C(=O)O)C(=O)O)C(=O)O DFRIXUYMTXMYAA-UHFFFAOYSA-N 0.000 description 1
- XVBDXPUCPBDYAJ-UHFFFAOYSA-N CC(C(C1=CC(=CC=C1)N)(C1=CC(=CC=C1)N)C)CCCCCCCC Chemical compound CC(C(C1=CC(=CC=C1)N)(C1=CC(=CC=C1)N)C)CCCCCCCC XVBDXPUCPBDYAJ-UHFFFAOYSA-N 0.000 description 1
- GUGLGYAIYJRFSA-UHFFFAOYSA-N COC(CCCCCCCCCCCCNCCNCCN)(OC)OC Chemical compound COC(CCCCCCCCCCCCNCCNCCN)(OC)OC GUGLGYAIYJRFSA-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- YUXIBTJKHLUKBD-UHFFFAOYSA-N Dibutyl succinate Chemical compound CCCCOC(=O)CCC(=O)OCCCC YUXIBTJKHLUKBD-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- XEEHRQPQNJOFIQ-UHFFFAOYSA-N N(C1=CC=CC=C1)CCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound N(C1=CC=CC=C1)CCCC(C(OC)(OC)OC)CCCCCCCC XEEHRQPQNJOFIQ-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- HDJGANPLOWXKTM-UHFFFAOYSA-N NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC Chemical compound NC(=O)NCCCC(C(OCC)(OCC)OCC)CCCCCCCC HDJGANPLOWXKTM-UHFFFAOYSA-N 0.000 description 1
- HNJYHRSYMUUVEX-UHFFFAOYSA-N NC(CC(C(OC)(OC)OC)CCCCCCCC)C Chemical compound NC(CC(C(OC)(OC)OC)CCCCCCCC)C HNJYHRSYMUUVEX-UHFFFAOYSA-N 0.000 description 1
- AJOYCSBPBSZRHI-UHFFFAOYSA-N NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C Chemical compound NC(CC(C(OCC)(OCC)OCC)CCCCCCCC)C AJOYCSBPBSZRHI-UHFFFAOYSA-N 0.000 description 1
- KCZYRUHGNZSIEY-UHFFFAOYSA-N NC=1C=C(C=CC1)C(CCCCCCCCC)C1=CC(=CC=C1)N Chemical compound NC=1C=C(C=CC1)C(CCCCCCCCC)C1=CC(=CC=C1)N KCZYRUHGNZSIEY-UHFFFAOYSA-N 0.000 description 1
- VVQRHMZIPYZPDL-UHFFFAOYSA-N NC=1C=C(OCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCCCOC2=CC(=CC=C2)N)C=CC1 VVQRHMZIPYZPDL-UHFFFAOYSA-N 0.000 description 1
- REVLAIHBLDVITK-UHFFFAOYSA-N NC=1C=C(OCCCCCCOC2=CC(=CC=C2)N)C=CC1 Chemical compound NC=1C=C(OCCCCCCOC2=CC(=CC=C2)N)C=CC1 REVLAIHBLDVITK-UHFFFAOYSA-N 0.000 description 1
- KTGXWDZUZLWXOF-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)C)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)C)CCCCCCCC KTGXWDZUZLWXOF-UHFFFAOYSA-N 0.000 description 1
- PEXBBTCNDBSFHT-UHFFFAOYSA-N NCCNCCCC(C(OC)(OC)OC)CCCCCCCC Chemical compound NCCNCCCC(C(OC)(OC)OC)CCCCCCCC PEXBBTCNDBSFHT-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 101001062854 Rattus norvegicus Fatty acid-binding protein 5 Proteins 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical class [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- VRJPMYDKXNTGFV-UHFFFAOYSA-N [3-(4-aminobenzoyl)oxyphenyl] 4-aminobenzoate Chemical compound C1=CC(N)=CC=C1C(=O)OC1=CC=CC(OC(=O)C=2C=CC(N)=CC=2)=C1 VRJPMYDKXNTGFV-UHFFFAOYSA-N 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- FPXWISWMBLVKOD-UHFFFAOYSA-N [4-(4-aminobenzoyl)oxyphenyl] 4-aminobenzoate Chemical compound C1=CC(N)=CC=C1C(=O)OC(C=C1)=CC=C1OC(=O)C1=CC=C(N)C=C1 FPXWISWMBLVKOD-UHFFFAOYSA-N 0.000 description 1
- PNVBTTRFUJULII-UHFFFAOYSA-N [C].[Pt]=S Chemical compound [C].[Pt]=S PNVBTTRFUJULII-UHFFFAOYSA-N 0.000 description 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- XRLHGXGMYJNYCR-UHFFFAOYSA-N acetic acid;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)=O.CC(O)COC(C)CO XRLHGXGMYJNYCR-UHFFFAOYSA-N 0.000 description 1
- JABXMSSGPHGCII-UHFFFAOYSA-N acetic acid;propane-1,2-diol Chemical compound CC(O)=O.CC(O)CO JABXMSSGPHGCII-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- XIWMTQIUUWJNRP-UHFFFAOYSA-N amidol Chemical compound NC1=CC=C(O)C(N)=C1 XIWMTQIUUWJNRP-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical group C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- BKDVBBSUAGJUBA-UHFFFAOYSA-N bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic acid Chemical compound C1=CC2C(C(O)=O)C(C(=O)O)C1C(C(O)=O)C2C(O)=O BKDVBBSUAGJUBA-UHFFFAOYSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- GSEZYWGNEACOIW-UHFFFAOYSA-N bis(2-aminophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1N GSEZYWGNEACOIW-UHFFFAOYSA-N 0.000 description 1
- MKFFVFISLKXOSB-UHFFFAOYSA-N bis(3-aminophenyl) benzene-1,3-dicarboxylate Chemical compound NC1=CC=CC(OC(=O)C=2C=C(C=CC=2)C(=O)OC=2C=C(N)C=CC=2)=C1 MKFFVFISLKXOSB-UHFFFAOYSA-N 0.000 description 1
- GUNJOTGKRMYBEL-UHFFFAOYSA-N bis(3-aminophenyl) benzene-1,4-dicarboxylate Chemical compound NC1=CC=CC(OC(=O)C=2C=CC(=CC=2)C(=O)OC=2C=C(N)C=CC=2)=C1 GUNJOTGKRMYBEL-UHFFFAOYSA-N 0.000 description 1
- TUQQUUXMCKXGDI-UHFFFAOYSA-N bis(3-aminophenyl)methanone Chemical compound NC1=CC=CC(C(=O)C=2C=C(N)C=CC=2)=C1 TUQQUUXMCKXGDI-UHFFFAOYSA-N 0.000 description 1
- FRCGXWDENTYRDC-UHFFFAOYSA-N bis(4-aminophenyl) benzene-1,3-dicarboxylate Chemical compound C1=CC(N)=CC=C1OC(=O)C1=CC=CC(C(=O)OC=2C=CC(N)=CC=2)=C1 FRCGXWDENTYRDC-UHFFFAOYSA-N 0.000 description 1
- CFTXGNJIXHFHTH-UHFFFAOYSA-N bis(4-aminophenyl) benzene-1,4-dicarboxylate Chemical compound C1=CC(N)=CC=C1OC(=O)C1=CC=C(C(=O)OC=2C=CC(N)=CC=2)C=C1 CFTXGNJIXHFHTH-UHFFFAOYSA-N 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- WKDNYTOXBCRNPV-UHFFFAOYSA-N bpda Chemical compound C1=C2C(=O)OC(=O)C2=CC(C=2C=C3C(=O)OC(C3=CC=2)=O)=C1 WKDNYTOXBCRNPV-UHFFFAOYSA-N 0.000 description 1
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- WOSVXXBNNCUXMT-UHFFFAOYSA-N cyclopentane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)C1C(O)=O WOSVXXBNNCUXMT-UHFFFAOYSA-N 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- DHDZMONMPFKUJO-UHFFFAOYSA-N decane-1,9-diamine Chemical compound CC(N)CCCCCCCCN DHDZMONMPFKUJO-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- 125000004427 diamine group Chemical group 0.000 description 1
- 229960002097 dibutylsuccinate Drugs 0.000 description 1
- OTARVPUIYXHRRB-UHFFFAOYSA-N diethoxy-methyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(OCC)CCCOCC1CO1 OTARVPUIYXHRRB-UHFFFAOYSA-N 0.000 description 1
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 description 1
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical compound C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical group CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003903 lactic acid esters Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical compound [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N methylimidazole Natural products CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- NSLGQFIDCADTAS-UHFFFAOYSA-N n,n-dimethyl-1,1-dipropoxymethanamine Chemical compound CCCOC(N(C)C)OCCC NSLGQFIDCADTAS-UHFFFAOYSA-N 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- VXXOYZOZDIQRPL-UHFFFAOYSA-N n,n-diphenylthiohydroxylamine Chemical compound C=1C=CC=CC=1N(S)C1=CC=CC=C1 VXXOYZOZDIQRPL-UHFFFAOYSA-N 0.000 description 1
- BPOZIJBDYFHEJR-UHFFFAOYSA-N n-(ethyldiazenyl)-4-methylaniline Chemical compound CCN=NNC1=CC=C(C)C=C1 BPOZIJBDYFHEJR-UHFFFAOYSA-N 0.000 description 1
- SJPFBRJHYRBAGV-UHFFFAOYSA-N n-[[3-[[bis(oxiran-2-ylmethyl)amino]methyl]phenyl]methyl]-1-(oxiran-2-yl)-n-(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC=1C=C(CN(CC2OC2)CC2OC2)C=CC=1)CC1CO1 SJPFBRJHYRBAGV-UHFFFAOYSA-N 0.000 description 1
- IQQYKULLKVYXCS-UHFFFAOYSA-N n-benzyldecan-1-amine Chemical compound CCCCCCCCCCNCC1=CC=CC=C1 IQQYKULLKVYXCS-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 229940017144 n-butyl lactate Drugs 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- OBKARQMATMRWQZ-UHFFFAOYSA-N naphthalene-1,2,5,6-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 OBKARQMATMRWQZ-UHFFFAOYSA-N 0.000 description 1
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 1
- OKBVMLGZPNDWJK-UHFFFAOYSA-N naphthalene-1,4-diamine Chemical compound C1=CC=C2C(N)=CC=C(N)C2=C1 OKBVMLGZPNDWJK-UHFFFAOYSA-N 0.000 description 1
- KQSABULTKYLFEV-UHFFFAOYSA-N naphthalene-1,5-diamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1N KQSABULTKYLFEV-UHFFFAOYSA-N 0.000 description 1
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 1
- GOGZBMRXLADNEV-UHFFFAOYSA-N naphthalene-2,6-diamine Chemical compound C1=C(N)C=CC2=CC(N)=CC=C21 GOGZBMRXLADNEV-UHFFFAOYSA-N 0.000 description 1
- HBJPJUGOYJOSLR-UHFFFAOYSA-N naphthalene-2,7-diamine Chemical compound C1=CC(N)=CC2=CC(N)=CC=C21 HBJPJUGOYJOSLR-UHFFFAOYSA-N 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- YTVNOVQHSGMMOV-UHFFFAOYSA-N naphthalenetetracarboxylic dianhydride Chemical compound C1=CC(C(=O)OC2=O)=C3C2=CC=C2C(=O)OC(=O)C1=C32 YTVNOVQHSGMMOV-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- UFOIOXZLTXNHQH-UHFFFAOYSA-N oxolane-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1OC(C(O)=O)C(C(O)=O)C1C(O)=O UFOIOXZLTXNHQH-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229960005335 propanol Drugs 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- ILVGAIQLOCKNQA-UHFFFAOYSA-N propyl 2-hydroxypropanoate Chemical compound CCCOC(=O)C(C)O ILVGAIQLOCKNQA-UHFFFAOYSA-N 0.000 description 1
- FOWDZVNRQHPXDO-UHFFFAOYSA-N propyl hydrogen carbonate Chemical compound CCCOC(O)=O FOWDZVNRQHPXDO-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 229940032159 propylene carbonate Drugs 0.000 description 1
- 229940116423 propylene glycol diacetate Drugs 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- JREWFSHZWRKNBM-UHFFFAOYSA-N pyridine-2,3,4,5-tetracarboxylic acid Chemical compound OC(=O)C1=CN=C(C(O)=O)C(C(O)=O)=C1C(O)=O JREWFSHZWRKNBM-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D179/00—Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen, with or without oxygen, or carbon only, not provided for in groups C09D161/00 - C09D177/00
- C09D179/04—Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
- C09D179/08—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nonlinear Science (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mathematical Physics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Manufacturing & Machinery (AREA)
Description
本發明係關於含有使用具有特定構造之二胺化合物所得之聚合物之液晶配向劑、液晶配向膜及液晶顯示元件。 The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element containing a polymer obtained by using a diamine compound having a specific structure.
液晶配向膜為液晶顯示元件中,為控制液晶之配向狀態而使用之構成構件。 The liquid crystal alignment film is a constituent member used for controlling the alignment state of the liquid crystal in the liquid crystal display element.
液晶顯示元件中之液晶配向膜之形成係使用例如以聚醯胺酸等之聚醯亞胺前驅物或可溶性聚醯亞胺等之聚合物作為主成分,將其溶解於溶劑中而成之液晶配向處理劑(亦簡稱為液晶配向劑)。接著,將其塗佈於TFT(薄膜電晶體)基板、附ITO(摻錫之氧化銦)之玻璃基板等上,並經燒成,形成聚合物之膜。目前,主要使用所謂的聚醯亞胺系之液晶配向膜作為液晶配向膜。 In the formation of the liquid crystal alignment film in the liquid crystal display device, for example, a polymer obtained by dissolving a polymer such as a polyimide or a polymerizable polyimide precursor such as polyacrylamide or a soluble polyimine in a solvent is used. Orientation treatment agent (also referred to as liquid crystal alignment agent). Next, it is applied onto a TFT (thin film transistor) substrate, a glass substrate to which ITO (tin-doped indium oxide) is attached, or the like, and is fired to form a film of a polymer. At present, a so-called polyimine-based liquid crystal alignment film is mainly used as a liquid crystal alignment film.
近幾年來,隨著液晶顯示元件之高精密化,而要求抑制液晶顯示元件之對比性降低或減低殘像現象,故所使用之液晶配向膜除了液晶之配像控制以外,亦要求各種性能。例如提高電壓保持率,或減少施加直流電壓時 之殘留電荷,加速因直流電壓所致之累積殘留電荷之緩和等,認為該等特性相當重要。 In recent years, with the high precision of liquid crystal display elements, it is required to suppress the contrast of the liquid crystal display elements from being lowered or to reduce the afterimage phenomenon. Therefore, the liquid crystal alignment film used requires various performances in addition to the image control of the liquid crystal. Such as increasing the voltage holding ratio or reducing the application of DC voltage The residual charge accelerates the relaxation of the accumulated residual charge due to the DC voltage, and is considered to be quite important.
聚醯亞胺系之液晶配向膜中,作為改善因上述直流電壓之施加所致之殘留電荷問題,且可縮短因直流電壓而發生之液晶顯示元件之殘像消失為止之時間者,除聚醯胺酸或含醯亞胺基之聚醯胺酸以外,已知有使用含有特定構造之3級胺之液晶配向劑者(參照例如專利文獻1)、使用原料中使用具有吡啶或咪唑骨架之特定二胺化合物之可溶性聚醯亞胺的液晶配向劑者(參照例如專利文獻2)等。 In the polyimine-based liquid crystal alignment film, as a problem of improving the residual charge due to the application of the DC voltage, and shortening the time until the afterimage of the liquid crystal display element due to the DC voltage disappears, In addition to an amino acid or a ruthenium group containing a quinone imine group, a liquid crystal alignment agent containing a tertiary amine having a specific structure is known (see, for example, Patent Document 1), and a specific pyridine or imidazole skeleton is used in the raw material. A liquid crystal alignment agent of a soluble polyimine of a diamine compound (see, for example, Patent Document 2).
通常該等液晶配向劑中係使用N-甲基吡咯烷酮作為溶劑。然而,N-甲基吡咯烷酮雖為溶解性優異、可使上述聚合物良好溶解,但另一方面在噴墨塗佈液晶配向劑時,大多會使突出部溶解。因此,要求不使用N-甲基吡咯烷酮作為溶劑之液晶配向劑。 Usually, N-methylpyrrolidone is used as a solvent in the liquid crystal alignment agents. However, N-methylpyrrolidone is excellent in solubility and can dissolve the polymer well. On the other hand, when the liquid crystal alignment agent is ink-jet-coated, the protruding portion is often dissolved. Therefore, a liquid crystal alignment agent which does not use N-methylpyrrolidone as a solvent is required.
專利文獻1:日本特開平9-316200號公報 Patent Document 1: Japanese Patent Laid-Open No. Hei 9-316200
專利文獻2:日本特開平10-104633號公報 Patent Document 2: Japanese Patent Laid-Open No. Hei 10-104633
然而,使用具有上述吡啶或咪唑骨架等之芳香族雜環之特定二胺化合物之聚醯胺酸及/或聚醯亞胺 (以下有時簡稱為聚合物)大多係對於N-吡咯烷酮以外之溶劑的溶解性差者。 However, polyamic acid and/or polyimine using a specific diamine compound having an aromatic heterocyclic ring such as the above pyridine or imidazole skeleton or the like (hereinafter sometimes referred to simply as a polymer) is often poor in solubility in a solvent other than N-pyrrolidone.
因此,液晶配向膜之形成所用之聚合物中,要求以可溶於N-甲基吡咯烷酮以外之溶劑之方式,實現優異之溶解性。 Therefore, in the polymer used for the formation of the liquid crystal alignment film, it is required to achieve excellent solubility in a manner other than a solvent other than N-methylpyrrolidone.
本發明之目的係提供一種含有由形成溶解性優異之聚合物所用之化合物所得之聚合物的液晶配向劑、使用該液晶配向劑所形成之液晶配向膜、及電壓保持率特性及源自殘留電荷之殘像特性優異之液晶顯示元件。 An object of the present invention is to provide a liquid crystal alignment agent containing a polymer obtained by forming a compound for use in a polymer having excellent solubility, a liquid crystal alignment film formed using the liquid crystal alignment agent, and a voltage retention property and a residual charge derived therefrom. A liquid crystal display element having excellent afterimage characteristics.
本發明人為達成上述目的而進行積極研究,發現具有新穎構造之本發明之特定二胺化合物,且發現含使用該二胺化合物所得之聚合物作為成分之液晶配向劑可達成上述目的。 The present inventors conducted active research to achieve the above object, and found a specific diamine compound of the present invention having a novel structure, and found that a liquid crystal alignment agent containing a polymer obtained by using the diamine compound as a component can achieve the above object.
亦即,本發明為具有以下要旨者。 That is, the present invention has the following gist.
1. 一種液晶配向劑,其特徵係含有自聚醯亞胺前驅物、及使該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺所組成群組選出之至少1種聚合物,該聚醯亞胺前驅物係使用含有自以下述式(1)及式(2)表示之二胺化合物所組成群組選出之1種以上之二胺成分所得者,
2. 如上述1所記載之液晶配向劑,其中前述聚醯亞胺前驅物係藉由使含有自以式(1)及式(2)表示之二胺化合物所組成群組選出之1種以上之二胺成分與四羧酸二酐反應獲得之聚醯胺酸。 2. The liquid crystal alignment agent according to the above-mentioned item 1, wherein the polyimine precursor is one or more selected from the group consisting of diamine compounds represented by the formulas (1) and (2). The polyamine acid obtained by reacting the diamine component with tetracarboxylic dianhydride.
3. 如上述1或2所記載之液晶配向劑,其中前述二胺化合物為自以下述式(3)及(4)所組成群組選出之1種以上,
4. 如上述1~3中任一項所記載之液晶配向劑,其中前述聚合物之含量在液晶配向劑中為1~20重量%。 4. The liquid crystal alignment agent according to any one of the above 1 to 3, wherein the content of the polymer is 1 to 20% by weight in the liquid crystal alignment agent.
5. 一種液晶配向膜,其特徵為塗佈如上述1~4中任一項所記載之液晶配向劑,經乾燥、燒結而得。 A liquid crystal alignment film obtained by coating the liquid crystal alignment agent according to any one of the above 1 to 4, which is dried and sintered.
6. 如上述5所記載之液晶配向膜,其中前述燒結溫度為50~300℃。 6. The liquid crystal alignment film according to the above 5, wherein the sintering temperature is 50 to 300 °C.
7. 如上述5或6所記載之液晶配向膜,其中燒結後之膜厚為5~300nm。 7. The liquid crystal alignment film according to the above 5 or 6, wherein the film thickness after sintering is 5 to 300 nm.
8. 一種液晶顯示元件,其具有如上述5~7中任一項所記載之液晶配向膜。 A liquid crystal display element comprising the liquid crystal alignment film according to any one of the above 5 to 7.
9. 一種二胺化合物,其係以下述式(1)及式(2)中之任一者表示,
10. 如上述9所記載之二胺化合物,其中式(1)及式(2)中之R5為氫。 10. The diamine compound according to the above 9, wherein R 5 in the formula (1) and the formula (2) is hydrogen.
11. 如上述9或10所記載之二胺化合物,其中式(1)及式(2)中之R4為甲基。 11. The diamine compound according to the above 9 or 10, wherein R 4 in the formula (1) and the formula (2) is a methyl group.
12. 一種二胺化合物,其係以下述式(3)及(4)中之任一者表示,
13. 一種聚合物,其係使用自上述9~12中任一項所記載之二胺化合物所組成群組選出之1種以上所得者。 A polymer obtained by using one or more selected from the group consisting of the diamine compounds described in any one of the above 9 to 12.
藉由使用本發明之二胺化合物,獲得溶解性優異之聚合物,且具有由含有該聚合物之液晶配向劑所形 成之液晶配向膜之液晶顯示元件具有優異之電壓保持率特性及源自殘留電荷之殘像特性,可作為輕量、薄型且低消耗電力之顯示裝置加以利用。 By using the diamine compound of the present invention, a polymer excellent in solubility is obtained, and has a shape of a liquid crystal alignment agent containing the polymer. The liquid crystal display element of the liquid crystal alignment film has excellent voltage retention characteristics and after-image characteristics derived from residual electric charge, and can be utilized as a display device which is lightweight, thin, and low in power consumption.
圖1係二胺化合物之前驅物的化合物(DA-A-2)之X射線構造解析像。 Fig. 1 is an X-ray structural analysis image of a compound (DA-A-2) of a precursor of a diamine compound.
使用本發明之化合物的二胺化合物(亦稱為特定二胺化合物)、且作為聚合物而形成之聚醯亞胺前驅物及/或使其聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺具有優異之溶解性,亦可溶於N-甲基吡咯烷酮以外之溶劑中。亦即,可提供至少一部份使用N-甲基吡咯烷酮以外之溶劑的液晶配向劑。 A polyamine compound (also referred to as a specific diamine compound) using the compound of the present invention, and a polyimide precursor formed as a polymer and/or a polyamidene precursor thereof The quinone imine has excellent solubility and can also be dissolved in a solvent other than N-methylpyrrolidone. That is, at least a portion of a liquid crystal alignment agent using a solvent other than N-methylpyrrolidone can be provided.
再者,由使用本發明之化合物的二胺化合物、且含有作為聚合物所形成之聚醯亞胺前驅物及/或使其聚醯亞胺前驅物予以醯亞胺化之聚醯亞胺的液晶配向劑所得之液晶配向膜可促進液晶配向膜中之電荷移動。 Further, a polyamine compound using a diamine compound of the present invention and containing a polyimine precursor formed as a polymer and/or a polyimide which is imidized by a polyimide precursor thereof The liquid crystal alignment film obtained by the liquid crystal alignment agent can promote the charge movement in the liquid crystal alignment film.
進而,具有電壓保持率高,且即使在高溫下長時間暴露後,仍可加速因直流電壓所致之累積殘留電荷緩和之特性。 Further, it has a high voltage holding ratio and can accelerate the relaxation of the accumulated residual charge due to the DC voltage even after exposure for a long time at a high temperature.
因此,具有由含使用本發明之二胺化合物之 聚醯亞胺前驅物及/或聚醯亞胺作為聚合物之液晶配向處理劑所得之液晶配向膜的液晶顯示元件成為信賴性優異者,可較好地使用於大畫面之高精密液晶電視等中。 Therefore, it has a diamine compound containing the use of the present invention. A liquid crystal display element of a liquid crystal alignment film obtained by using a polyimine precursor and/or a polyimine as a liquid crystal alignment treatment agent of a polymer is excellent in reliability, and can be preferably used in a high-definition liquid crystal television or the like for a large screen. in.
以下,針對本發明之化合物亦即特定二胺化合物、使用該特定二胺化合物所得之聚合物、含該聚合物作為成分之液晶配向劑、使用其形成之液晶配向膜、及具有該液晶配向膜之液晶顯示元件加以說明。 Hereinafter, the compound of the present invention, that is, a specific diamine compound, a polymer obtained by using the specific diamine compound, a liquid crystal alignment agent containing the polymer as a component, a liquid crystal alignment film formed using the same, and the liquid crystal alignment film The liquid crystal display element will be described.
本發明之特定二胺化合物係以下述式(1)及式(2)中之任一者表示之化合物。 The specific diamine compound of the present invention is a compound represented by any one of the following formulas (1) and (2).
又,下述式(1)及式(2)中,Boc表示第三丁氧基羰基,以下各式中亦同。 Further, in the following formulas (1) and (2), Boc represents a third butoxycarbonyl group, and the same applies to the following formulae.
上述式(1)及式(2)表示之特定二胺化合物中,較好為以下之式(3)及(4)表示之二胺化合物。又,下述式(3)及式(4)中,Me表示甲基,以下之各式中亦同。 Among the specific diamine compounds represented by the above formulas (1) and (2), the diamine compounds represented by the following formulas (3) and (4) are preferred. Further, in the following formulas (3) and (4), Me represents a methyl group, and the same applies to the following various formulae.
製造本發明之以上述式(1)及式(2)之任一者表示之特定二胺化合物之方法並無特別限制。 The method for producing the specific diamine compound represented by any one of the above formulas (1) and (2) of the present invention is not particularly limited.
例如,準備所對應之以下述式(5)及式(6)表示之二硝基化合物,藉由使該等硝基還原,轉換成胺基而得。 For example, the dinitro compound represented by the following formula (5) and formula (6) is prepared by converting the nitro group to an amine group.
其中,以上述式(5)及式(6)表示之二硝基化合物中,以適於以上述式(3)及式(4)表示之二胺化合物的合成之以下述式(7)及式(8)表示之二硝基化合物較佳。 In the dinitro compound represented by the above formula (5) and formula (6), the synthesis of the diamine compound represented by the above formula (3) and formula (4) is represented by the following formula (7) and The dinitro compound represented by the formula (8) is preferred.
使以上述式(7)及式(8)之二硝基化合物表示之例如以式(5)及上述式(6)之二硝基化合物還原 之方法並無特別限制,通常可應用使用鈀-碳、氧化鉑、阮尼(Raney)鎳、鐵、氯化錫、鉑黑、銠-氧化鋁、硫化鉑碳等作為觸媒,在乙酸乙酯、甲苯、四氫呋喃、二噁烷、醇系等溶劑中,使用氫氣、聯胺、氯化氫、氯化銨等進行之反應。 Reduction of the dinitro compound represented by the above formula (7) and formula (8), for example, by the dinitro compound of the formula (5) and the above formula (6) The method is not particularly limited, and generally, palladium-carbon, platinum oxide, Raney nickel, iron, tin chloride, platinum black, lanthanum-alumina, platinum sulfide carbon or the like can be used as a catalyst, in acetic acid B. In a solvent such as an ester, toluene, tetrahydrofuran, dioxane or an alcohol, a reaction using hydrogen, hydrazine, hydrogen chloride, ammonium chloride or the like is carried out.
本發明之聚合物係由使用含有上述特定二胺化合物之二胺成分所得之聚醯亞胺前驅物、以及使該聚醯亞胺前驅物醯亞胺化所得之聚醯亞胺所組成群組選出之至少1種聚合物,尤其係藉由含有上述特定二胺化合物之二胺成分與四羧酸二酐之反應所得之聚醯胺酸、及使該聚醯胺酸進行脫水閉環所得之聚醯亞胺。 The polymer of the present invention is composed of a polyimine precursor obtained by using a diamine component containing the above specific diamine compound, and a polyimine obtained by imidating the polyimine precursor quinone. Selecting at least one polymer, in particular, a polylysine obtained by reacting a diamine component containing the above specific diamine compound with a tetracarboxylic dianhydride, and a polycondensation obtained by subjecting the polyamic acid to dehydration ring closure Yttrium.
該等聚醯亞胺前驅物及聚醯亞胺均含於液晶配向劑中,可有效使用作為用於獲得液晶配向膜之聚合物。 These polyimine precursors and polyimine are contained in a liquid crystal alignment agent, and can be effectively used as a polymer for obtaining a liquid crystal alignment film.
使用本發明之聚合物所得之液晶配向膜中,用於形成該液晶配向膜之二胺成分中之特定二胺化合物之含有比例愈多,則電壓保持率愈高,且即使高溫下長時間暴露後,仍可加速因直流電壓所致之累積殘留電荷之緩和。 In the liquid crystal alignment film obtained by using the polymer of the present invention, the more the content ratio of the specific diamine compound in the diamine component for forming the liquid crystal alignment film, the higher the voltage holding ratio and the long-time exposure even at a high temperature. After that, the relaxation of the accumulated residual charge due to the DC voltage can still be accelerated.
為提高上述電特性,較好液晶配向劑中含有之二胺成分之5莫耳%以上為特定二胺化合物。更好二胺成分之10莫耳%以上為特定二胺化合物,又更好為15莫耳%以上。 In order to improve the above electrical characteristics, it is preferred that 5 mol% or more of the diamine component contained in the liquid crystal alignment agent is a specific diamine compound. More preferably, 10 mol% or more of the diamine component is a specific diamine compound, and more preferably 15 mol% or more.
亦可使二胺成分之100莫耳%為特定二胺化合物,但就塗佈液晶配向劑時之均勻塗佈性之觀點而言,特定二胺化合物較好為二胺成分之80莫耳%以下,更好為70莫耳%以下。 Further, 100 mol% of the diamine component may be a specific diamine compound, but the specific diamine compound is preferably 80 mol% of the diamine component from the viewpoint of uniform coatability when the liquid crystal alignment agent is applied. Hereinafter, it is preferably 70 mol% or less.
本發明中,在不損及本發明效果之範圍內,除特定二胺化合物以外,亦可併用其他二胺化合物作為用以形成聚合物之二胺成分。以下列舉其他二胺化合物之具體例。 In the present invention, in addition to the specific diamine compound, other diamine compounds may be used in combination as the diamine component for forming the polymer, within the range not impairing the effects of the present invention. Specific examples of other diamine compounds are listed below.
對-苯二胺、2,3,5,6-四甲基-對-苯二胺、2,5-二甲基-對-苯二胺、間-苯二胺、2,4-二甲基-間-苯二胺、2,5-二胺基甲苯、2,6-二胺基甲苯、2,5-二胺基酚、2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄基醇、2,4-二胺基苄基醇、4,6-二胺基間苯二甲酚、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-聯苯、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺基二苯基醚、2,2’-二胺基二苯基醚、2,3’-二胺基二苯基醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯 基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫基二苯胺、3,3’-硫基二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、2,3’-二胺基二苯基胺、N-甲基(4,4’-二胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、1,2-雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、4,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、3,3’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,3’-[1,3-伸苯基雙(亞甲基)]二苯胺、1,4-伸苯基雙[(4-胺基苯基)橋亞甲基(methano)]、1,4-伸苯基雙[(3-胺基苯基)橋亞甲基]、1,3-伸苯基雙[(4-胺基苯 基)橋亞甲基]、1,3-伸苯基雙[(3-胺基苯基)橋亞甲基]、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、N,N’-(1,4-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,4-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-雙(4-胺基苯基)對苯二甲醯胺、N,N’-雙(3-胺基苯基)對苯二甲醯胺、N,N’-雙(4-胺基苯基)間苯二甲醯胺、N,N’-雙(3-胺基苯基)間苯二甲醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧基)二苯基碸、2,2’-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2’-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、1,3-雙(4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-(3-胺基苯氧基)庚烷、 1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、1,11-(4-胺基苯氧基)十一碳烷、1,11-(3-胺基苯氧基)十一碳烷、1,12-(4-胺基苯氧基)十二碳烷、1,12-(3-胺基苯氧基)十二碳烷、雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基)甲烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、1,11-二胺基十一碳烷、1,12-二胺基十二碳烷等。 p-Benzyldiamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, m-phenylenediamine, 2,4-dimethyl Base-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3,5-diamine Phenolic, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoisoxoxyl, 4,4'-diaminobiphenyl, 3 , 3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4, 4'-Diaminobiphenyl, 3,3'-difluoro-4,4'-biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4' -diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenyl Methane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diamino Diphenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-di Aminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonate Mercaptodiphenylamine, bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl-bis(4-aminobenzene) Base) decane, dimethyl-bis(3-aminophenyl)decane, 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4'-diaminodiphenyl Amine, 3,3'-diaminodiphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'-diaminodi Phenylamine, N-methyl(4,4'-diaminodiphenyl)amine, N-methyl(3,3'-diaminodiphenyl)amine, N-methyl (3,4 '-Diaminodiphenyl)amine, N-methyl(2,2'-diaminodiphenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4 , 4'-diaminobenzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2 '-Diaminobenzophenone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-Diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-double (4-Aminophenyl)ethane, 1,2-bis(3-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,3-bis(3- Aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4) - Phenyl)methane, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl) Benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4 , 4'-[1,4-phenylenebis(methylene)]diphenylamine, 4,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,4'- [1,4-phenylphenylbis(methylene)]diphenylamine, 3,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,3'-[1,4 -phenylphenylbis(methylene)]diphenylamine, 3,3'-[1,3-phenylenebis(methylene)]diphenylamine, 1,4-phenylene bis[(4-amine) Phenyl)methanom, 1,4-phenylene bis[(3-aminophenyl) bridged methylene], 1,3-phenylene bis[(4-amino) benzene (methylene), 1,3-phenylene bis[(3-aminophenyl) bridged methylene], 1,4-phenylene bis(4-aminobenzoate), 1,4-phenylphenylbis(3-aminobenzoate), 1,3-phenylene bis(4-aminobenzoate), 1,3-phenylene bis(3-amine Benzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl)isophthalate Dicarboxylate, bis(3-aminophenyl)isophthalate, N,N'-(1,4-phenylene)bis(4-aminobenzamide), N,N '-(1,3-Extended phenyl)bis(4-aminobenzamide), N,N'-(1,4-phenylene)bis(3-aminobenzamide), N , N'-(1,3-phenylene) bis(3-aminobenzamide), N,N'-bis(4-aminophenyl)terephthalamide, N,N' - bis(3-aminophenyl)terephthalamide, N,N'-bis(4-aminophenyl)m-xylyleneamine, N,N'-bis(3-aminobenzene) Benzyl decylamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy)diphenylanthracene, 2,2'-double [4-(4-Aminophenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2'-bis (4 -aminophenyl)hexafluoropropane, 2, 2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2'-bis(4-amino group Phenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methylphenyl)propane, 1,3-bis(4- Aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, 1,4-bis(3-amine Phenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1,5-bis(3-aminophenoxy)pentane, 1,6-bis (4- Aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,7-(3- Aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane 1,9-bis(3-aminophenoxy)decane, 1,10-(4-aminophenoxy)decane, 1,10-(3-aminophenoxy)decane, 1,11-(4-Aminophenoxy)undecane, 1,11-(3-aminophenoxy)undecane, 1,12-(4-aminophenoxy) Dioxane, 1,12-(3-aminophenoxy)dodecane, bis(4-aminocyclohexyl)methane, bis(4-amino-3-methylcyclohexyl)methane, 1 , 3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1, 8-Diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 1,11-diaminoundecane, 1,12-diaminododeca Alkane, etc.
又,作為其他二胺化合物可列舉為具有烷基、含氟烷基、芳香環、脂肪族環、雜環及由該等所成之環狀取代基作為二胺側鏈之二胺化合物。該二胺化合物之具體例可列舉為以下述式[DA1]~[DA26]表示之二胺化合物。 Further, examples of the other diamine compound include a diamine compound having an alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring, a hetero ring, and a cyclic substituent formed therefrom as a diamine side chain. Specific examples of the diamine compound include diamine compounds represented by the following formulas [DA1] to [DA26].
上述式[DA1]~[DA5]中,R11為碳數1~22之烷基或含氟烷基。 In the above formula [DA1] to [DA5], R 11 is an alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkyl group.
上述式[DA6]~[DA9]中,R12為-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-,R13為碳數1~22之烷基或含氟烷基。 In the above formula [DA6]~[DA9], R 12 is -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-, and R 13 is An alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkyl group.
上述式[DA10]及式[DA11]中,R14為-O-、-OCH2-、-CH2O-、-COOCH2-、或-CH2OCO-。 In the above formula [DA10] and formula [DA11], R 14 is -O-, -OCH 2 -, -CH 2 O-, -COOCH 2 -, or -CH 2 OCO-.
R15為碳數1~22之烷基、烷氧基、含氟烷基、或含氟烷氧基。 R 15 is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group.
上述式[DA12]~[DA14]中,R16為-COO-、 -OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-或-CH2-。 In the above formula [DA12]~[DA14], R 16 is -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 -or-CH 2 -.
R17為碳數1~22之烷基、烷氧基、含氟烷基、或含氟烷氧基。 R 17 is an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group.
上述式[DA15]及式[DA16]中,R18為-COO-、-OCO-、-CONH-、-NHCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-、-CH2-、-O-、或-NH-。 In the above formula [DA15] and formula [DA16], R 18 is -COO-, -OCO-, -CONH-, -NHCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 -, -CH 2 -, -O-, or -NH-.
R19為氟基、氰基、三氟甲基、硝基、偶氮基、甲醯基、乙醯基、乙醯氧基、或羥基。 R 19 is a fluorine group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a decyl group, an ethyl group, an ethoxy group, or a hydroxyl group.
再者,其他二胺化合物亦列舉為以下述式[DA27]表示之二胺基矽氧烷等。 Further, the other diamine compound is exemplified by a diamine sulfoxane represented by the following formula [DA27].
上述式[DA27]中,m為1~10之整數。 In the above formula [DA27], m is an integer of 1 to 10.
其他二胺化合物亦可依據使用含聚合物之液晶配向劑,形成液晶配向膜時之其液晶配向性、電壓保持、累積電荷等之特性,混合1種或2種以上使用。 The other diamine compound may be used in combination with one or two or more kinds of the liquid crystal alignment film, the voltage retention, and the charge accumulation when the liquid crystal alignment film is formed by using a liquid crystal alignment agent containing a polymer.
本發明之聚合物的聚醯胺酸可藉由使含有上述特定二胺化合物之二胺成分與四羧酸二酐反應而合成。 The polylysine of the polymer of the present invention can be synthesized by reacting a diamine component containing the above specific diamine compound with a tetracarboxylic dianhydride.
用於獲得本發明之聚醯胺酸之與二胺成分反應之四羧酸二酐並無特別限制。其較佳具體例列舉如下。 The tetracarboxylic dianhydride for reacting the polyamine acid of the present invention with the diamine component is not particularly limited. Preferred specific examples are as follows.
列舉為均苯四酸二酐、2,3,6,7-萘四羧酸二酐、1,2,5,6-萘四羧酸二酐、1,4,5,8-萘四羧酸二酐、 2,3,6,7-蒽四羧酸二酐、1,2,5,6-蒽四羧酸二酐、3,3’,4,4’-聯苯四羧酸二酐、2,3,3’,4-聯苯四羧酸二酐、雙(3,4-二羧基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸二酐、雙(3,4-二羧基苯基)碸、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,4-二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸二酐、2,6-雙(3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碸四羧酸二酐、3,4,9,10-嵌二萘四羧酸二酐、1,3-二苯基-1,2,3,4-環丁烷四羧酸二酐、氧基二酞基四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環丁烷四羧酸二酐、2,3,4,5-四氫呋喃四羧酸二酐、3,4-二羧基-1-環己基琥珀酸二酐、2,3,5-三羧基環戊基乙酸二酐、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐、雙環[3,3,0]辛烷-2,4,6,8-四羧酸二酐、雙環[4,3,0]壬烷-2,4,7,9-四羧酸二酐、雙環[4,4,0]癸烷-2,4,7,9-四羧酸二酐、雙環[4,4,0]癸烷-2,4,8,10-四羧酸二酐、三環[6.3.0.0<2,6>]十一碳烷-3,5,9,11-四羧酸二酐、1,2,3,4-丁烷四羧酸二酐、4-(2,5-二氧代四氫呋喃-3-基)-1,2,3,4-四氫萘-1,2-二羧酸二酐、雙環[2,2,2]辛-7-烯-2,3,5,6-四羧酸二酐、5-(2,5-二氧代四氫呋喃基)-3-甲基-3-環己烷-1,2-二羧酸二酐、四環 [6,2,1,1,0,2,7]十二烷-4,5,9,10-四羧酸二酐、3,5,6-三羧基降冰片烷-2:3,5:6二羧酸二酐、1,2,4,5-環己烷四羧酸二酐等。 Listed as pyromellitic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 1,2,5,6-naphthalenetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic acid Acid dianhydride, 2,3,6,7-nonanedicarboxylic dianhydride, 1,2,5,6-fluorene tetracarboxylic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, 2, 3,3',4-biphenyltetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, double 3,4-dicarboxyphenyl)anthracene, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1,1,3,3 ,3-hexafluoro-2,2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethylnonane, bis(3,4-dicarboxyphenyl) Diphenyldecane, 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3',4,4'-diphenyl Terpene tetracarboxylic dianhydride, 3,4,9,10-insene naphthalene tetracarboxylic dianhydride, 1,3-diphenyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, oxygen Di-indenyltetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4, 5-cyclohexanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl-1, 2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclobutane Alkane tetracarboxylic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic acid , 3,4-dicarboxy-1-cyclohexyl succinic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydro- 1-naphthalene succinic dianhydride, bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride, bicyclo[4,3,0]nonane-2,4,7, 9-tetracarboxylic dianhydride, bicyclo[4,4,0]nonane-2,4,7,9-tetracarboxylic dianhydride, bicyclo[4,4,0]nonane-2,4,8, 10-tetracarboxylic dianhydride, tricyclo[6.3.0.0<2,6>]undecane-3,5,9,11-tetracarboxylic dianhydride, 1,2,3,4-butane IV Carboxylic dianhydride, 4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic dianhydride, bicyclo[2,2, 2] oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 5-(2,5-dioxotetrahydrofuranyl)-3-methyl-3-cyclohexane-1,2 -Dicarboxylic dianhydride, tetracyclic [6,2,1,1,0,2,7]dodecane-4,5,9,10-tetracarboxylic dianhydride, 3,5,6-tricarboxynorbornane-2:3,5 : 6 dicarboxylic dianhydride, 1,2,4,5-cyclohexane tetracarboxylic dianhydride, and the like.
四羧酸二酐可依據使用含有聚合物之液晶配向劑,形成液晶配向膜時之其液晶配向性、電壓保持、累積電荷等之特性,併用1種或2種以上。 The tetracarboxylic dianhydride may be one or more selected from the group consisting of a liquid crystal alignment film containing a polymer and a liquid crystal alignment property, a voltage holding property, and an accumulated electric charge.
藉由四羧酸二酐與二胺成分之反應,獲得本發明之聚醯胺酸可使用習知合成方法。 A conventional synthesis method can be obtained by reacting a tetracarboxylic dianhydride with a diamine component to obtain the polyproline of the present invention.
例如,在有機溶劑中使四羧酸二酐與二胺成分反應之方法。四羧酸二酐與二胺成分之反應,基於較容易進行且不會產生副產物方面,在有機溶劑中進行較有利。 For example, a method of reacting a tetracarboxylic dianhydride with a diamine component in an organic solvent. The reaction of the tetracarboxylic dianhydride with the diamine component is advantageously carried out in an organic solvent based on the ease of carrying out and the absence of by-products.
四羧酸二酐與二胺成分反應所用之有機溶劑若為使產生之聚醯胺酸溶解者即無特別限制。其具體例列舉如下。 The organic solvent used for the reaction of the tetracarboxylic dianhydride and the diamine component is not particularly limited as long as the polyamic acid produced is dissolved. Specific examples thereof are as follows.
N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-甲基己內醯胺、二甲基亞碸、四甲基脲、吡啶、二甲基碸、六甲基亞碸、γ-丁內酯、異丙醇、甲氧基甲基戊醇、二戊烯、乙基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、甲基溶纖素、乙基溶纖素、甲基溶纖素乙酸酯、乙基溶纖素乙酸酯、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇單丁基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、丙二醇第三丁基醚、二丙二醇單甲基醚、二乙二醇、二乙二醇單乙酸酯、二乙二醇二甲基 醚、二丙二醇單乙酸酯單甲基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇單乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單乙酸酯單丙基醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲基醚、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁基醚、二異丁基酮、甲基環己酮、丙基醚、二己基醚、二噁烷、正己烷、正戊烷、正辛烷、二乙基醚、環己酮、碳酸乙烯酯、碳酸丙烯酯、乳酸甲基、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、二甘醇二甲醚(diglyme)、4-羥基-4-甲基-2-戊酮等。該等可單獨使用,亦可混合使用。再者,即使是不溶解聚醯胺酸之溶劑,亦可在不使生成之聚醯胺酸析出之範圍內,混合於上述溶劑中使用。 N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, dimethyl hydrazine, tetramethylurea , pyridine, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, isopropanol, methoxymethylpentanol, dipentene, ethyl amyl ketone, methyl decyl ketone, methyl Ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cellosolve, ethyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl Carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl Ether, propylene glycol, tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl Ether, dipropylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetic acid Ester monopropyl ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl Butyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl ketone, methylcyclohexanone, propyl ether, dihexyl ether, dioxane, n-hexane, n-pentane , n-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, Methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, diglyme, 4-hydroxy-4-methyl-2-pentyl Ketones, etc. These may be used singly or in combination. Further, even if the solvent which does not dissolve the poly-proline is used, it may be mixed and used in the solvent in the range in which the produced polyamine is not precipitated.
又,有機溶劑中之水分係妨礙聚合反應,進而成為使產生之聚醯胺酸水解之原因,故有機溶劑較好使用經脫水乾燥者。 Further, since the water in the organic solvent hinders the polymerization reaction and further causes hydrolysis of the produced polylysine, the organic solvent is preferably used by dehydration.
四羧酸二酐與二胺成分在有機溶劑中反應時,列舉有下列方法:攪拌使二胺成分分散或溶解於有機溶劑中而成之溶液,直接添加四羧酸二酐,或分散或溶解於有機溶劑中後添加之方法;相反地於將二胺成分添加於使四羧酸二酐分散或溶解於有機溶劑中而成之溶液中之方 法;交互添加四羧酸二酐與二胺成分之方法等,可使用該等之任一種方法。且,四羧酸二酐或二胺成分由複數種化合物組成時,可以預先混合之狀態反應,亦可個別依序反應,亦可為進而使個別反應之低分子量體混合反應成為高分子量體而獲得聚合物。 When the tetracarboxylic dianhydride and the diamine component are reacted in an organic solvent, the following method may be mentioned: a solution obtained by dispersing or dissolving a diamine component in an organic solvent, directly adding a tetracarboxylic dianhydride, or dispersing or dissolving a method of post-addition in an organic solvent; conversely, adding a diamine component to a solution obtained by dispersing or dissolving a tetracarboxylic dianhydride in an organic solvent The method of alternately adding a tetracarboxylic dianhydride and a diamine component, and the like can be used. Further, when the tetracarboxylic dianhydride or the diamine component is composed of a plurality of compounds, it may be reacted in a state of being mixed in advance, or may be reacted individually or sequentially, or the low-molecular weight of the individual reaction may be mixed and reacted into a high molecular weight body. The polymer was obtained.
四羧酸二酐與二胺成分反應時之聚合溫度可選擇-20~150℃之任意溫度,較好為-5~100℃之範圍。 The polymerization temperature in the reaction of the tetracarboxylic dianhydride with the diamine component may be selected from any temperature of from -20 to 150 ° C, preferably from -5 to 100 ° C.
又,反應可以任意濃度進行,但濃度過低時難以獲得高分子量之共聚物,濃度過高時反應液之黏性過高而難以均勻地攪拌,故四羧酸二酐與二胺成分在反應溶液中之合計濃度較好為1~50質量%,更好為5~30質量%。反應初期係在高濃度下進行,隨後可追加有機溶劑。 Further, the reaction can be carried out at any concentration. However, when the concentration is too low, it is difficult to obtain a copolymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction liquid is too high to be uniformly stirred, so that the tetracarboxylic dianhydride and the diamine component are reacted. The total concentration in the solution is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction is carried out at a high concentration, and then an organic solvent can be added.
獲得聚醯胺酸之聚合反應中,四羧酸二酐之合計莫耳數與二胺成分之合計莫耳數之比,較好為0.8~1.2。與一般之聚縮合反應相同,其莫耳比愈接近1.0則生成之聚醯胺酸之分子量愈大。 In the polymerization reaction for obtaining polyglycine, the ratio of the total number of moles of the tetracarboxylic dianhydride to the total number of moles of the diamine component is preferably from 0.8 to 1.2. As with the general polycondensation reaction, the closer the molar ratio is to 1.0, the larger the molecular weight of the polylysine produced.
本發明中之聚醯亞胺前驅物之一種的聚醯胺酸酯可藉以下所示之(1)~(3)之方法合成。 The polyglycolate of one of the polyimine precursors of the present invention can be synthesized by the methods (1) to (3) shown below.
聚醯胺酸酯可藉由使上述聚醯胺酸進行酯化而合成。 Polyammonium ester can be synthesized by esterifying the above polyamic acid.
具體而言,可在有機溶劑存在下,使聚醯胺酸與酯化 劑在-20℃~150℃,較好在0℃~50℃反應30分鐘~24小時,較好1~4小時而合成。 Specifically, the polyglycine can be esterified with an organic solvent in the presence of an organic solvent. The agent is synthesized at -20 ° C to 150 ° C, preferably at 0 ° C to 50 ° C for 30 minutes to 24 hours, preferably 1 to 4 hours.
作為酯化劑較好為可藉由純化容易地去除者,列舉為N,N-二甲基甲醯胺二甲基乙縮醛、N,N-二甲基甲醯胺二乙基乙縮醛、N,N-二甲基甲醯胺二丙基乙縮醛、N,N-二甲基甲醯胺二新戊基丁基乙縮醛、N,N-二甲基甲醯胺二第三丁基乙縮醛、1-甲基-3-對-甲苯基三氮烯(1-methyl-3-p-tolyltriazene)、1-乙基-3-對-甲苯基三氮烯、1-丙基-3-對-甲苯基三氮烯、4-(4,6-二甲氧基-1,3,5-三嗪-2-基)-4-甲基嗎啉鎓氯化物等。酯化劑之添加量相對於聚醯胺酸之重複單位1莫耳,較好為2~6莫耳當量。 The esterifying agent is preferably one which can be easily removed by purification, and is exemplified by N,N-dimethylformamide dimethyl acetal and N,N-dimethylformamide diethyl condensate. Aldehyde, N,N-dimethylformamide dipropyl acetal, N,N-dimethylformamide dinepentylbutyl acetal, N,N-dimethylformamide Third butyl acetal, 1-methyl-3-p-tolyltriazene, 1-ethyl-3-p-tolyltriazene, 1 -propyl-3-p-tolyltriazene, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride, etc. . The amount of the esterifying agent to be added is 1 mol, more preferably 2 to 6 mol equivalent, based on the repeating unit of the polyamic acid.
上述反應中所用之溶劑就聚合物之溶解性而言以N,N-二甲基甲醯胺、N-甲基-2-吡咯烷酮、γ-丁內酯較佳,該等可使用1種或混合2種以上使用。合成時之濃度就不易引起聚合物析出,且易於獲得高分子量體之觀點而言,較好為1~30質量%,更好為5~20質量%。 The solvent used in the above reaction is preferably N,N-dimethylformamide, N-methyl-2-pyrrolidone or γ-butyrolactone in terms of solubility of the polymer, and one type of these may be used or Mix two or more types. The concentration at the time of the synthesis is less likely to cause precipitation of the polymer, and is preferably from 1 to 30% by mass, more preferably from 5 to 20% by mass, from the viewpoint of easily obtaining a high molecular weight body.
聚醯胺酸酯可由四羧酸二酯二氯化物與含上述特定二胺之二胺合成。 The polyglycolate can be synthesized from a tetracarboxylic acid diester dichloride and a diamine containing the above specific diamine.
具體而言,可在鹼與有機溶劑存在下,使四羧酸二酯二氯化物與二胺在-20℃~150℃,較好在0℃~50℃反應30分鐘~24小時,較好1~4小時而合成。 Specifically, the tetracarboxylic acid diester dichloride and the diamine may be reacted in the presence of a base and an organic solvent at -20 ° C to 150 ° C, preferably at 0 ° C to 50 ° C for 30 minutes to 24 hours, preferably. It is synthesized in 1~4 hours.
前述鹼可使用吡啶、三乙胺、4-二甲胺基吡啶等,但為使反應穩定地進行較好為吡啶。鹼之添加量為容易去除之量,且就容易獲得高分子量體之觀點而言,相對於四羧酸二酯二氯化物較好為2~4倍莫耳。 As the base, pyridine, triethylamine, 4-dimethylaminopyridine or the like can be used, but in order to stably carry out the reaction, pyridine is preferred. The amount of the base to be added is an amount which is easily removed, and from the viewpoint of easily obtaining a high molecular weight body, it is preferably from 2 to 4 moles per mole of the tetracarboxylic acid diester dichloride.
上述反應中所用之溶劑就單體及聚合物之溶解性而言,以N-甲基-2-吡咯烷酮、γ-丁內酯較佳,該等可使用1種或混合2種以上使用。合成時之聚合物濃度就不易引起聚合物析出,且容易獲得高分子量體之觀點而言,較好為1~30質量%,更好為5~20質量%。 The solvent to be used in the above-mentioned reaction is preferably N-methyl-2-pyrrolidone or γ-butyrolactone in terms of the solubility of the monomer and the polymer. These may be used alone or in combination of two or more. The polymer concentration at the time of synthesis is less likely to cause precipitation of the polymer, and is preferably from 1 to 30% by mass, more preferably from 5 to 20% by mass, from the viewpoint of easily obtaining a high molecular weight body.
且,為了防止四羧酸二酯二氯化物之水解,聚醯胺酸酯之合成中所用之溶劑較好儘可能經脫水,反應較好在氮氣環境中,並防止外氣混入。 Further, in order to prevent hydrolysis of the tetracarboxylic acid diester dichloride, the solvent used in the synthesis of the polyglycolate is preferably dehydrated as much as possible, and the reaction is preferably carried out in a nitrogen atmosphere to prevent incorporation of outside air.
聚醯胺酸酯可藉由使四羧酸二酯與含上述特定二胺之二胺進行聚縮合而合成。 The polyperurethane can be synthesized by polycondensing a tetracarboxylic acid diester with a diamine containing the above specific diamine.
具體而言可在縮合劑、鹼及有機溶劑存在下,使四羧酸二酯與二胺在0℃~150℃,較好在0℃~100℃反應30分鐘~24小時,較好3~15小時而合成。 Specifically, the tetracarboxylic acid diester and the diamine can be reacted in the presence of a condensing agent, a base and an organic solvent at 0 ° C to 150 ° C, preferably at 0 ° C to 100 ° C for 30 minutes to 24 hours, preferably 3~. Synthesized in 15 hours.
前述縮合劑可使用亞磷酸三苯酯、二環己基碳二醯亞胺、1-乙基-3-(3-二甲胺基丙基)碳二醯亞胺鹽酸鹽、N,N’-羰基二咪唑、二甲氧基-1,3,5-三嗪基甲基嗎啉鎓、O-(苯并三唑-1-基)-N,N,N’,N’-四甲基脲鎓四氟硼酸鹽、O-(苯并三唑-1-基)-N,N,N’,N’-四甲基脲鎓六 氟亞磷酸鹽、(2,3-二氫-2-硫代-3-苯并噁唑基)磺酸二苯酯等。縮合劑之添加量相對於四羧酸二酯較好為2~3倍莫耳。 As the condensing agent, triphenyl phosphite, dicyclohexylcarbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, N, N' can be used. -carbonyldiimidazole, dimethoxy-1,3,5-triazinylmethylmorpholinium, O-(benzotriazol-1-yl)-N,N,N',N'-tetra Urea urea tetrafluoroborate, O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium Fluorated phosphite, diphenyl (2,3-dihydro-2-thio-3-benzoxazolyl)sulfonate, and the like. The amount of the condensing agent added is preferably from 2 to 3 moles per mole of the tetracarboxylic acid diester.
前述鹼可使用吡啶、三乙胺等3級胺。鹼之添加量為容易去除之量,且就容易獲得高分子量體之觀點而言,相對於二胺成分較好為2~4倍莫耳。 As the base, a tertiary amine such as pyridine or triethylamine can be used. The amount of the base to be added is an amount which is easily removed, and from the viewpoint of easily obtaining a high molecular weight body, it is preferably 2 to 4 times moles relative to the diamine component.
又,上述反應中,藉由添加路易斯酸作為添加劑而使反應有效率地進行。路易斯酸較好為氯化鋰、溴化鋰等鹵化鋰。路易斯酸之添加量相對於二胺成分較好為0~1.0倍莫耳。 Further, in the above reaction, the reaction is efficiently carried out by adding a Lewis acid as an additive. The Lewis acid is preferably a lithium halide such as lithium chloride or lithium bromide. The amount of the Lewis acid added is preferably from 0 to 1.0 times the molar amount of the diamine component.
上述3種聚醯胺酸酯之合成方法中,為獲得高分子量之聚醯胺酸酯,最好為上述(1)或(2)之合成法。 In the method for synthesizing the above three polyglycolates, in order to obtain a high molecular weight polyphthalate, the synthesis method of the above (1) or (2) is preferred.
如上述獲得之聚醯胺酸酯之溶液可藉由邊充分攪拌邊注入於弱溶劑中,使聚合物析出。進行數次析出,以弱溶劑洗淨後,於常溫或加熱乾燥,可獲得純化之聚醯胺酸酯之粉末。弱溶劑並無特別限制,列舉為水、甲醇、乙醇、己烷、丁基溶纖素、丙酮、甲苯等。 The solution of the polyphthalate obtained as described above can be precipitated by injecting into a weak solvent while stirring well. The precipitated powder is washed several times, washed with a weak solvent, and dried at room temperature or under heating to obtain a purified polyphthalate powder. The weak solvent is not particularly limited and is exemplified by water, methanol, ethanol, hexane, butyl cellosolve, acetone, toluene, and the like.
聚醯胺酸酯之重量平均分子量較好為5,000~300,000,更好為10,000~200,000。且,數平均分子量較好為2,500~150,000,更好為5,000~100,000。 The polyamine has a weight average molecular weight of preferably from 5,000 to 300,000, more preferably from 10,000 to 200,000. Further, the number average molecular weight is preferably from 2,500 to 150,000, more preferably from 5,000 to 100,000.
本發明之聚合物亦可由使上述聚醯亞胺前驅物經醯亞胺化之聚醯亞胺所組成。本發明之聚醯亞胺中,醯胺酸基 之脫水閉環率(醯亞胺化率)未必需為100%,可依據用途或目的任意調整。 The polymer of the present invention may also be composed of a polyimine which is ruthenium imidized with the above polyimide precursor. In the polyimine of the present invention, a proline group The dehydration ring closure ratio (醯 imidization ratio) is not necessarily 100% and can be arbitrarily adjusted depending on the purpose or purpose.
獲得本發明之聚醯亞胺時,使聚醯亞胺前驅物醯亞胺化之方法列舉為直接加熱聚醯胺酸等聚醯亞胺前驅物之溶液的熱醯亞胺化,將觸媒添加於聚醯亞胺前驅物之溶液中之觸媒醯亞胺化。 When the polyimine of the present invention is obtained, the method of imidating the polyimine precursor ruthenium is exemplified by direct heating of a solution of a polyamidene precursor such as polyaminic acid, which is a thermochemical imidization. The catalyst oxime added to the solution of the polyimide precursor is imidized.
使聚醯胺酸等聚醯亞胺前驅物在溶液中熱醯亞胺化時之溫度為100~400℃,較好為120~250℃,且較好邊將因醯亞胺化反應生成之水排除於系統外邊進行之方法。 The temperature of the polyamidene precursor such as polylysine in the solution is imidized in a solution at a temperature of 100 to 400 ° C, preferably 120 to 250 ° C, and preferably formed by the imidization reaction. The method of removing water outside the system.
聚醯胺酸等之聚醯亞胺前驅物之觸媒醯亞胺化可將鹼性觸媒與酸酐添加於聚醯胺酸之溶液中,且在-20~250℃,較好在0~180℃攪拌而進行。 The ruthenium imidization of a polyimide precursor such as polyaminic acid can add a basic catalyst and an acid anhydride to a solution of polyamic acid at -20 to 250 ° C, preferably 0 to 0. This was carried out by stirring at 180 °C.
鹼性觸媒之量為醯胺酸基之0.5~30莫耳倍,較好為2~20莫耳倍,酸酐之量為醯胺酸基之1~50莫耳倍,較好為3~30莫耳倍。 The amount of the alkaline catalyst is 0.5 to 30 moles of the prolyl group, preferably 2 to 20 moles, and the amount of the anhydride is 1 to 50 moles of the amidate group, preferably 3~. 30 moles.
至於鹼性觸媒可列舉為吡啶、三乙胺、三甲胺、三丁胺、三辛胺等,其中吡啶由於具有反應進行之適當鹼性故較佳。 The basic catalyst may, for example, be pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine. Among them, pyridine is preferred because it has a suitable basicity for the reaction.
酸酐可列舉為乙酸酐、偏苯三酸酐、均苯四甲酸酐等,其中使用乙酸酐時因反應結束後之純化容易故較佳。 The acid anhydride may, for example, be acetic anhydride, trimellitic anhydride or pyromellitic anhydride. When acetic anhydride is used, purification after completion of the reaction is preferred, which is preferred.
藉由觸媒醯亞胺化之醯亞胺化率可藉由調節觸媒量與反應溫度、反應時間加以控制。 The imidization ratio of the imidization by the catalyst oxime can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time.
自反應溶液回收生成之聚醯亞胺時,較好將反應溶液倒入弱溶劑中使之沉澱。沉澱中使用之弱溶劑可列舉為甲醇、丙酮、己烷、丁基溶纖素、庚烷、甲基乙基酮、甲基異丁基酮、乙醇、甲苯、苯、水等。 When the resulting polyimine is recovered from the reaction solution, the reaction solution is preferably poured into a weak solvent to precipitate. The weak solvent used in the precipitation may, for example, be methanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water or the like.
倒入弱溶劑中而沉澱之聚合物經過濾回收後,可在常壓或減壓下,於常溫或加熱乾燥。又,使沉澱回收之聚合物再溶解於有機溶劑中,且重複2~10次之再沉澱回收操作時,可減少聚合物中之雜質。此時之弱溶劑列舉為例如醇類、酮類、烴等,使用自該等中選出之三種以上之弱溶劑時,可更提高純化效率故較佳。 The polymer precipitated by pouring into a weak solvent is recovered by filtration, and dried at normal temperature or under heat at normal pressure or reduced pressure. Further, when the precipitate-recovered polymer is redissolved in an organic solvent, and the reprecipitation recovery operation is repeated 2 to 10 times, impurities in the polymer can be reduced. The weak solvent at this time is, for example, an alcohol, a ketone, a hydrocarbon or the like. When three or more kinds of weak solvents selected from the above are used, the purification efficiency can be further improved, which is preferable.
本發明之液晶配向劑中所含之聚醯亞胺前驅物及聚醯亞胺之分子量,考慮使用自其所得之塗膜之強度、塗膜形成時之作業性及塗膜之均勻性,以GPC(凝膠滲透層析)法測定之重量平均分子量較好為5000~1000000,更好為10000~150000。 The molecular weight of the polyimine precursor and the polyimine contained in the liquid crystal alignment agent of the present invention is considered by using the strength of the coating film obtained therefrom, the workability at the time of formation of the coating film, and the uniformity of the coating film. The weight average molecular weight measured by the GPC (gel permeation chromatography) method is preferably from 5,000 to 1,000,000, more preferably from 10,000 to 150,000.
本發明之液晶配向劑係用以形成液晶配向膜之塗佈液,且為將用以形成高分子被膜之高分子成分溶解於溶劑中而成之溶液。此處,高分子成分中含上述本發明之聚合物中之至少一種聚合物。 The liquid crystal alignment agent of the present invention is a solution for forming a coating liquid for a liquid crystal alignment film and dissolving a polymer component for forming a polymer film in a solvent. Here, the polymer component contains at least one of the above-described polymers of the present invention.
高分子成分之含量在液晶配向劑中較好為1~20質量%,更好為3~15質量%,最好為3~10質量%。 The content of the polymer component is preferably from 1 to 20% by mass, more preferably from 3 to 15% by mass, most preferably from 3 to 10% by mass, based on the liquid crystal alignment agent.
本發明中,上述高分子成分之全部可為上述 本發明之聚合物,亦可在不損及本發明效果之範圍內含有其他聚合物。高分子成分含有其他聚合物時,其含量相對於本發明之聚合物1質量份較好為0.05~4質量份,更好為0.1~3質量份。 In the present invention, all of the polymer components may be the above The polymer of the present invention may contain other polymers within the range not impairing the effects of the present invention. When the polymer component contains another polymer, the content thereof is preferably 0.05 to 4 parts by mass, more preferably 0.1 to 3 parts by mass, per part by mass of the polymer of the present invention.
上述其他聚合物列舉為例如使用上述特定二胺化合物以外之二胺化合物,與四羧酸二酐成分反應所得之聚醯胺酸或使其聚醯胺酸予以醯亞胺化之聚醯亞胺等。 The above other polymer is exemplified by, for example, a polyamine compound obtained by using a diamine compound other than the above specific diamine compound, a polyaminic acid obtained by reacting a tetracarboxylic dianhydride component, or a polyamidimide obtained by imidating a polyamic acid. Wait.
本發明之液晶配向劑中所用之溶劑較好為使高分子成分溶解之有機溶劑,其具體例列舉於下。 The solvent used in the liquid crystal alignment agent of the present invention is preferably an organic solvent in which a polymer component is dissolved, and specific examples thereof are as follows.
有機溶劑列舉為N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-甲基己內醯胺、2-吡咯烷酮、N-乙基吡咯烷酮、N-乙烯基吡咯烷酮、二甲基亞碸、四甲基脲、吡啶、二甲基碸、六甲基亞碸、γ-丁內酯、1,3-二甲基-咪唑啶酮、乙基戊基酮、甲基壬基酮、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、環己酮、碳酸伸乙酯、碳酸伸丙酯、二甘醇二甲醚、4-羥基-4-甲基-2-戊酮等。該等可單獨使用,亦可混合使用。 The organic solvent is exemplified by N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone, N- Ethylpyrrolidone, N-vinylpyrrolidone, dimethyl hydrazine, tetramethylurea, pyridine, dimethyl hydrazine, hexamethylarylene, γ-butyrolactone, 1,3-dimethyl-imidazole Ketone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethyl carbonate, propyl carbonate, digan Alcohol dimethyl ether, 4-hydroxy-4-methyl-2-pentanone, and the like. These may be used singly or in combination.
本發明之液晶配向劑亦可具有上述高分子成分以外之成分。其例為在塗佈液晶配向劑時提高膜厚均勻性或表面平滑性之溶劑或化合物、提高液晶配向膜與基板之密著性之化合物等。 The liquid crystal alignment agent of the present invention may have a component other than the above polymer component. Examples thereof include a solvent or a compound which improves uniformity of film thickness or surface smoothness when a liquid crystal alignment agent is applied, a compound which improves adhesion between a liquid crystal alignment film and a substrate, and the like.
提高膜厚均勻性或表面平滑性之溶劑列舉為對於液晶配向處理劑中之高分子成分之溶解性小之弱溶劑。弱溶劑之具體例列舉如下。 The solvent which improves the uniformity of the film thickness or the surface smoothness is a weak solvent which is small in solubility in the polymer component in the liquid crystal alignment treatment agent. Specific examples of the weak solvent are listed below.
例如異丙醇、甲氧基甲基戊醇、甲基溶纖素、乙基溶纖素、丁基溶纖素、甲基溶纖素乙酸酯、乙基溶纖素乙酸酯、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯、乙二醇、乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇單丁基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、丙二醇第三丁基醚、二丙二醇單甲基醚、二乙二醇、二乙二醇單乙酸酯、二乙二醇二甲基醚、二丙二醇單乙酸酯單甲基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二醇單乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單乙酸酯單丙基醚、3-甲基-3-甲氧基丁基乙酸酯、三丙二醇甲基醚、3-甲基-3-甲氧基丁醇、二異丙基醚、乙基異丁基醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁基醚、二異丁基酮、甲基環己烷、丙基醚、二己基醚、1-己醇、正己烷、正戊烷、正辛烷、二乙基醚、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、1-甲氧基-2-丙醇、1-乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基-2-丙醇、丙二醇單乙酸酯、丙二醇二乙酸酯、丙二醇-1-單甲基醚-2-乙酸酯、丙二醇-1-單乙基醚-2-乙酸酯、二丙二醇、2-(2-乙氧基丙氧基)丙醇、乳酸甲酯、乳酸乙酯、乳酸正丙酯、乳酸正丁酯、乳酸異戊酯等具有低表面張力之溶劑等。 For example, isopropanol, methoxymethylpentanol, methyl cellosolve, ethyl cellosolve, butyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl card Alcohol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol Monoacetate, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol Monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl Ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, Diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl ketone, methylcyclohexane, propyl ether, dihexyl ether, 1-hexanol, n-hexane, n-pentane, n-octyl Alkane, diethyl ether, lactic acid Ester, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, 3-ethoxy Methyl ethyl propyl propionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, 3-methoxypropane Butyl acrylate, 1-methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, propylene glycol Acetate, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, 2-(2-ethoxyl) A solvent having a low surface tension such as propyloxy)propanol, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate or isoamyl lactate.
該等弱溶劑可單獨使用一種或混合複數種使用。使用如上述之弱溶劑時,弱溶劑較好為液晶配向劑中所含溶劑全部之5~80質量%,更好為20~60質量%。 These weak solvents may be used singly or in combination of plural kinds. When a weak solvent as described above is used, the weak solvent is preferably from 5 to 80% by mass, more preferably from 20 to 60% by mass, based on the total amount of the solvent contained in the liquid crystal alignment agent.
塗佈液晶配向劑時提高膜厚均勻性或表面平滑性之化合物列舉為氟系界面活性劑、聚矽氧系界面活性劑、非離子系界面活性劑等。 The compound which improves the film thickness uniformity or the surface smoothness at the time of apply|coating a liquid-crystal aligning agent is a fluorine-type surfactant, a polysiloxane surfactant, and a nonionic surfactant.
更具體而言,列舉為例如EF TOP(註冊商標)EF301、EF303、EF352(以上為Tokemu Products公司製造)、MAGAFAC(註冊商標)F171、F173、R-30(以上為大日本油墨公司製造),FLORARD FC430、FC431(以上為住友3M公司製造),Asahi Guard(註冊商標)AG710(以上為旭硝子公司製造)、SURFLON(註冊商標)S-382、SC101、SC102、SC103、SC104、SC105、SC106(以上為AGC Semi Chemical公司製造)等。該等界面活性劑之使用比例相對於液晶配向處理劑中含有之高分子成分100質量份,較好為0.01~2質量份,更好為0.01~1質量份。 More specifically, for example, EF TOP (registered trademark) EF301, EF303, EF352 (above, manufactured by Tokemu Products Co., Ltd.), MAGAFAC (registered trademark) F171, F173, R-30 (above, manufactured by Dainippon Ink Co., Ltd.), FLORARD FC430, FC431 (above is Sumitomo 3M), Asahi Guard (registered trademark) AG710 (above is manufactured by Asahi Glass Co., Ltd.), SURFLON (registered trademark) S-382, SC101, SC102, SC103, SC104, SC105, SC106 (above) It is manufactured by AGC Semi Chemical Co., Ltd.). The use ratio of the surfactant is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment agent.
提高液晶配向膜與基板之密著性之化合物之具體例列舉為以下所示之含有官能性矽烷之化合物或含有環氧基之化合物等。 Specific examples of the compound which improves the adhesion between the liquid crystal alignment film and the substrate are the following compounds containing a functional decane or a compound containing an epoxy group.
例如,3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3- 脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧基伸乙基)-3-胺基丙基三甲氧基矽烷、N-雙(氧基伸乙基)-3-胺基丙基三乙氧基矽烷、乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮水甘油基-2,4-己二醇、N,N,N’,N’-四縮水甘油基-間-二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷、N,N,N’,N’-四縮水甘油基-4,4’-二胺基二苯基甲烷等。 For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N- (2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3- Ureapropyl propyl trimethoxy decane, 3-ureidopropyl triethoxy decane, N-ethoxycarbonyl-3-aminopropyl trimethoxy decane, N-ethoxycarbonyl-3-amino group Propyltriethoxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecylpropyltriethylamine, 10-trimethoxydecyl-1 ,4,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diazaindole Acid ester, 9-triethoxydecyl-3,6-diazadecyl acetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-amino Propyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxydecane, N-bis(oxyethyl) 3-aminopropyltrimethoxydecane, N-bis(oxyethyl)-3-aminopropyltriethoxydecane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether , propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, Glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, N,N,N',N '-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane, N,N,N',N'-tetraglycidyl Base-4,4'-diaminodiphenylmethane and the like.
使用提高與基板之密著性之化合物時,其使用量相對於液晶配向處理劑所含有之高分子成分100質量份,較好為0.1~30質量份,更好為1~20質量份。使用量未達0.1質量份時無法期待密著性改善之效果,高於30質量份時會有液晶配向性變差之情況。 When the compound is used to improve the adhesion to the substrate, the amount thereof is preferably 0.1 to 30 parts by mass, more preferably 1 to 20 parts by mass, per 100 parts by mass of the polymer component contained in the liquid crystal alignment agent. When the amount used is less than 0.1 part by mass, the effect of improving the adhesion cannot be expected, and when it is more than 30 parts by mass, the liquid crystal alignment property may be deteriorated.
本發明之液晶配向劑除上述成分以外,只要在不損及本發明效果之範圍內,亦可添加用以使液晶配向膜之介電率或導電性等之電特性變化之介電體或導電物質,再者,亦可添加目的為提高作成液晶配向膜時之膜的硬度或緻密度之交聯性化合物等。 In addition to the above components, the liquid crystal alignment agent of the present invention may be added with a dielectric or a conductive material for changing the electrical properties such as the dielectric constant or the conductivity of the liquid crystal alignment film as long as the effects of the present invention are not impaired. Further, a cross-linking compound or the like which is intended to increase the hardness or density of the film when the liquid crystal alignment film is formed may be added.
本發明之液晶配向劑可塗佈於基板上,經乾燥、燒成形成塗膜後,經摩擦處理或照光等進行配向處理,而作為液晶配向膜使用。此外,在垂直配向用途等中可在未經配向處理作為液晶配向膜使用。 The liquid crystal alignment agent of the present invention can be applied onto a substrate, dried, and fired to form a coating film, and then subjected to alignment treatment by rubbing treatment or light irradiation, and used as a liquid crystal alignment film. Further, it can be used as a liquid crystal alignment film in an unaligned treatment in a vertical alignment use or the like.
使用之基板只要是透明性高之基板即無特別限制,可使用玻璃基板、或丙烯酸基板或聚碳酸酯基板等塑膠基板等。且,使用形成液晶驅動用之ITO電極等之基板就製程簡化之觀點而言較佳。又,反射型之液晶顯示元件亦可使用單面之基板係矽晶圓等不透明物,則該情況下之電極亦可使用鋁等之反射光之材料。 The substrate to be used is not particularly limited as long as it is a substrate having high transparency, and a glass substrate or a plastic substrate such as an acrylic substrate or a polycarbonate substrate can be used. Further, it is preferable from the viewpoint of simplifying the process using a substrate on which an ITO electrode for liquid crystal driving or the like is formed. Further, as the reflective liquid crystal display element, an opaque object such as a single-sided substrate-based wafer may be used. In this case, a material such as aluminum or the like may be used as the electrode.
液晶配向劑之塗佈方法並無特別限制,但工業上一般係以網版印刷、平版印刷、軟板印刷、噴墨印刷等進行。至於其他塗佈方法有浸漬法、輥塗法、狹縫塗佈法、旋轉塗佈法,可依據目的使用該等。 The coating method of the liquid crystal alignment agent is not particularly limited, but industrially, it is generally carried out by screen printing, lithography, flexographic printing, inkjet printing or the like. As for other coating methods, there are a dipping method, a roll coating method, a slit coating method, and a spin coating method, and these can be used depending on the purpose.
尤其,本發明之液晶配向劑可選擇多種對所含有之高分子(聚合物)成分之溶解性優異之溶劑進行調製,例如亦可適當地使用於例如噴墨法等中。 In particular, the liquid crystal alignment agent of the present invention can be prepared by various solvents which are excellent in solubility of the polymer (polymer) component contained therein, and can be suitably used, for example, in an inkjet method or the like.
於基板上塗佈液晶配向劑後之乾燥係以加熱板等加熱手段,在40~130℃,較好50~110℃下進行20~600秒,較好40~300秒,使溶劑蒸發,形成塗膜。 After the liquid crystal alignment agent is applied onto the substrate, the drying is performed by heating means such as a hot plate at 40 to 130 ° C, preferably 50 to 110 ° C for 20 to 600 seconds, preferably 40 to 300 seconds, to evaporate the solvent. Coating film.
於基板上塗佈液晶配向劑並乾燥後之燒成可藉加熱板、烘箱、IR烘箱等加熱手段,在50~300℃,較好80~250℃下進行5~120分鐘,較好進行8~60分鐘,使聚醯亞胺前驅物經聚醯亞胺化形成醯亞胺化聚合物塗膜。 The liquid crystal alignment agent is coated on the substrate and dried, and then fired by heating means, oven, IR oven, etc., at 50 to 300 ° C, preferably 80 to 250 ° C for 5 to 120 minutes, preferably 8 ~60 minutes, the polyimine precursor was polyimidized to form a ruthenium-imided polymer coating film.
燒成後所形成之塗膜厚度太厚時對於液晶顯示元件之消耗電力方面不利,太薄則會有液晶顯示元件之信賴性下降之情況,故較好為5~300nm,更好為10~100nm。使液晶水平配向或傾斜配向時係以摩擦或偏光紫外線照射等配向處理該燒成後之塗膜。 When the thickness of the coating film formed after firing is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element, and if it is too thin, the reliability of the liquid crystal display element may be lowered, so it is preferably 5 to 300 nm, more preferably 10 to 10. 100nm. When the liquid crystal is aligned horizontally or obliquely, the film after the firing is treated by alignment such as rubbing or polarized ultraviolet irradiation.
本發明之液晶顯示元件為藉上述製造方法,自本發明之液晶配向劑在基板上形成液晶配向膜,獲得附液晶配向膜之基板後,以習知方法製作液晶胞,成為液晶顯示元件者。 In the liquid crystal display device of the present invention, a liquid crystal alignment film is formed on a substrate from the liquid crystal alignment agent of the present invention, and a substrate having a liquid crystal alignment film is obtained, and a liquid crystal cell is produced by a known method to obtain a liquid crystal display element.
液晶胞製作之例,可列舉為準備形成有液晶配向膜之一對附液晶配向膜之基板,於一片基板之液晶配向膜上散佈隔離材,以使液晶配向膜面成為內側之方式,再貼合另一片基板,減壓注入液晶並密封之方法,或,將液晶滴加於散佈有隔離材之液晶配向膜面上後貼合基板並進行密封之方法等。此時隔離材之厚度係規定液晶顯示元件中之基板間之液晶厚度,較好為1~30μm,更好為2~10μm。 Examples of the liquid crystal cell formation include a substrate on which a liquid crystal alignment film is formed, and a spacer is disposed on a liquid crystal alignment film of one substrate so that the liquid crystal alignment film surface becomes inside. In combination with another substrate, a liquid crystal is injected under reduced pressure and sealed, or a liquid crystal is dropped on a liquid crystal alignment film surface on which a spacer is dispersed, and the substrate is bonded and sealed. The thickness of the separator at this time is a liquid crystal thickness between the substrates in the liquid crystal display element, and is preferably from 1 to 30 μm, more preferably from 2 to 10 μm.
如上述,使用本發明之液晶配向劑形成液晶配向膜所製造之液晶顯示元件成為信賴性優異者,且可較好地利用於大畫面且高精密液晶電視等中。 As described above, the liquid crystal display element produced by forming the liquid crystal alignment film using the liquid crystal alignment agent of the present invention is excellent in reliability, and can be preferably used in a large-screen, high-precision liquid crystal television or the like.
以下列舉實施例及比較例,更詳細說明本發明,但本發明並不解釋為受限於該等實施例。 The invention is illustrated in more detail below by way of examples and comparative examples, but the invention is not construed as being limited to the examples.
以下列出本發明之合成例、實施例及比較例中使用之化合物之簡寫與構造。 The abbreviations and structures of the compounds used in the synthesis examples, examples and comparative examples of the present invention are listed below.
(有機溶劑) (Organic solvents)
DMF:N,N-二甲基甲醯胺 DMF: N,N-dimethylformamide
THF:四氫呋喃 THF: tetrahydrofuran
NMP:N-甲基-2-吡咯烷酮 NMP: N-methyl-2-pyrrolidone
GBL:γ-丁內酯 GBL: γ-butyrolactone
BCS:乙二醇單丁醚 BCS: ethylene glycol monobutyl ether
(四羧酸二酐) (tetracarboxylic dianhydride)
BDA:1,2,3,4-丁烷四羧酸二酐 BDA: 1,2,3,4-butane tetracarboxylic dianhydride
PMDA:均苯四酸二酐 PMDA: pyromellitic dianhydride
CBDA:1,2,3,4-環丁烷四羧酸二酐 CBDA: 1,2,3,4-cyclobutane tetracarboxylic dianhydride
BODA:雙環[3.3.0]辛烷-2,4,6,8-四羧酸二酐 BODA: bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride
(二胺化合物) (diamine compound)
ODA:4,4’-氧基二苯胺 ODA: 4,4'-oxydiphenylamine
DDM:4,4’-二胺基二苯基甲烷 DDM: 4,4'-diaminodiphenylmethane
DA-B:下述式DA-B之二胺 DA-B: diamine of the following formula DA-B
以下顯示1H-NMR及分子量之測定、以及單結晶X射線構造解析之方法。 The method of measuring 1 H-NMR, molecular weight, and single crystal X-ray structure analysis is shown below.
裝置:傅立葉轉換型超傳導核磁共振裝置(FT-NMR)INOVA-400(Varian公司製造)400MHz Device: Fourier transform type superconducting nuclear magnetic resonance apparatus (FT-NMR) INOVA-400 (manufactured by Varian) 400 MHz
溶劑:氘化二甲基亞碸(DMSO-d6)或氘化氯仿(CDCl3) Solvent: deuterated dimethyl sulfoxide (DMSO-d 6) or deuterated chloroform (CDCl 3)
標準物質:四甲基矽烷(TMS) Reference material: tetramethyl decane (TMS)
累加次數:8或32 Accumulated times: 8 or 32
〔單結晶X射線構造解析〕 [Single crystal X-ray structure analysis]
裝置:APEX2(Bruker公司製造) Device: APEX2 (manufactured by Bruker)
測定溫度:298.0K Measuring temperature: 298.0K
X射線:Cu X-ray: Cu
〔分子量測定〕 [Molecular weight determination]
聚合物之分子量係使用昭和電工公司製造之常溫凝膠滲透層析(GPC)裝置(GPC-101)、Shodex公司製造之管柱(KD-803、KD-805),如下列般測定。 The molecular weight of the polymer was measured using a room temperature gel permeation chromatography (GPC) apparatus (GPC-101) manufactured by Showa Denko Co., Ltd., and a column (KD-803, KD-805) manufactured by Shodex Co., Ltd., as follows.
管柱溫度:50℃ Column temperature: 50 ° C
溶離液:N,N’-二甲基甲醯胺(作為添加劑,為溴化鋰一水合物(LiBr‧H2O)係30mmol/L(升),磷酸‧無水結晶(o-磷酸)係30mmol/L,四氫呋喃(THF)係10ml/L) Dissolution: N,N'-dimethylformamide (as an additive, lithium bromide monohydrate (LiBr‧H 2 O) system 30 mmol/L (liter), phosphoric acid ‧ anhydrous crystal (o-phosphoric acid) 30 mmol / L, tetrahydrofuran (THF) system 10ml / L)
流速:1.0ml/分鐘 Flow rate: 1.0ml/min
校正線作成用標準樣品:TOSOH公司製造TSK標準聚環氧乙烷(分子量約900000、150000、100000、及30000)及Polymer Library公司製造聚乙二醇(分子量約12000、4000、及1000)。 Standard sample for calibration line preparation: TSK standard polyethylene oxide (molecular weights of about 900,000, 150,000, 100,000, and 30,000) manufactured by TOSOH Corporation and polyethylene glycol (molecular weights of about 12,000, 4000, and 1000) manufactured by Polymer Library.
藉以下所示之3步驟之路徑合成芳香族二胺化合物(DA-A)。又,芳香族二胺化合物(DA-A)相當於上述式(3)之特定二胺化合物。 The aromatic diamine compound (DA-A) was synthesized by the three-step route shown below. Further, the aromatic diamine compound (DA-A) corresponds to a specific diamine compound of the above formula (3).
使4-羥基甲基-5-甲基咪唑鹽酸鹽(25.4g,171mmol)懸浮於DMF(102g)中,在27℃添加三乙胺(34.6g,342mmol)。接著,以15分鐘內滴加使二碳酸二第三丁酯(41.1g,188mmol)溶解於DMF(25g)而成之溶液。隨後,攪拌反應混合物18小時,以HPLC(薄層層析)確認原料消失。接著,藉過濾去除所析出之固體,濃縮濾液並乾燥。將甲苯(127g)添加於所得油狀物中,界過濾去除所析出之白色固體。隨後,濃縮濾液,並乾燥獲得黃色油狀之1N-Boc-4-羥基甲基-5-甲基咪唑(DA-A-1)及3N-Boc-4-羥基甲基-5-甲基咪唑(DA-C-1)之混合物(收量36.19g,收率100%)。自1H-NMR得知2種類之異構比為60:40。 4-Hydroxymethyl-5-methylimidazolium hydrochloride (25.4 g, 171 mmol) was suspended in DMF (102 g), and triethylamine (34.6 g, 342 mmol). Next, a solution obtained by dissolving dibutyl succinate (41.1 g, 188 mmol) in DMF (25 g) was added dropwise over 15 minutes. Subsequently, the reaction mixture was stirred for 18 hours, and the disappearance of the starting material was confirmed by HPLC (thin layer chromatography). Next, the precipitated solid was removed by filtration, and the filtrate was concentrated and dried. Toluene (127 g) was added to the obtained oil, and the precipitated white solid was removed by filtration. Subsequently, the filtrate was concentrated and dried to give 1N-Boc-4-hydroxymethyl-5-methylimidazole (DA-A-1) and 3N-Boc-4-hydroxymethyl-5-methylimidazole as a yellow oil. A mixture of (DA-C-1) (yield 36.19 g, yield 100%). The isomer ratio of the two species was found to be 60:40 from 1 H-NMR.
(DA-A-1)1H-NMR(CDCl3,δppm):8.05(s,1H,-N=C(H)-N-),4.74(t,J=5.4Hz,1H,OH),4.56(d,J=5.4Hz,2H,CH2),2.11(s,3H,-C=C(N)CH3),1.56(s,9H,t-Bu)。 (DA-A-1) 1 H-NMR (CDCl 3 , δ ppm): 8.05 (s, 1H, -N=C(H)-N-), 4.74 (t, J = 5.4 Hz, 1H, OH), 4.56 (d, J = 5.4 Hz, 2H, CH 2 ), 2.11 (s, 3H, -C=C(N)CH 3 ), 1.56 (s, 9H, t-Bu).
(DA-C-1)1H-NMR(CDCl3,δppm):8.03(s,1H,-N=C(H)-N-),4.83(t,J=5.4Hz,1H,OH),4.29(d,J=5.4Hz,2H,CH2),2.36(s,3H,-C=C(N)CH3),1.55(s,9H,t-Bu)。 (DA-C-1) 1 H-NMR (CDCl 3, δppm): 8.03 (s, 1H, -N = C (H) -N -), 4.83 (t, J = 5.4Hz, 1H, OH), 4.29 (d, J = 5.4 Hz, 2H, CH 2 ), 2.36 (s, 3H, -C=C(N)CH 3 ), 1.55 (s, 9H, t-Bu).
將1N-Boc-4-羥基甲基-5-甲基咪唑(DA-A-1)及3N-Boc-4-羥基甲基-5-甲基咪唑(DA-C-1)之混合物(35.8g,168.5mmol)溶解於DMF(175g)中,添加三乙胺(40.9g,404mmol),冷卻至3℃,在25分鐘內滴加使3,5-二硝基苯甲醯氯(50.5g,219mmol)溶解於DMF(51g)中之溶液。隨後,在20℃攪拌反應混合物3小時,測定HPLC後,由於原料殘留使用量中之5%,故再添加3,5-二硝基苯甲醯氯(11.7g,50.6mmol),攪拌16小時,以HPLC確認原料已消失。接著,於反應液中添加乙酸乙酯/己烷(2/1(容積比))之混合溶液(680mL),以水(220g)洗淨有機相3次。隨後,過濾析出物,以乙酸乙酯(50g)洗淨固體2次並乾燥,獲得1N-Boc-4-(3,5-二硝基苯甲醯氧基甲基)-5-甲基咪唑(DA-A-2)(收量27.4g,收率40%)。 a mixture of 1N-Boc-4-hydroxymethyl-5-methylimidazole (DA-A-1) and 3N-Boc-4-hydroxymethyl-5-methylimidazole (DA-C-1) (35.8 g, 168.5 mmol) dissolved in DMF (175 g), added triethylamine (40.9 g, 404 mmol), cooled to 3 ° C, and added 3,5-dinitrobenzoguanidine chloride (50.5 g) over 25 minutes , 219 mmol) a solution dissolved in DMF (51 g). Subsequently, the reaction mixture was stirred at 20 ° C for 3 hours, and after HPLC was measured, 3,5-dinitrobenzimid chloride (11.7 g, 50.6 mmol) was further added and stirred for 16 hours due to 5% of the residual amount of the raw materials. It was confirmed by HPLC that the starting material had disappeared. Next, a mixed solution (680 mL) of ethyl acetate/hexane (2/1 (volume ratio)) was added to the reaction liquid, and the organic phase was washed three times with water (220 g). Subsequently, the precipitate was filtered, and the solid was washed twice with ethyl acetate (50 g) and dried to obtain 1N-Boc-4-(3,5-dinitrobenzyloxymethyl)-5-methylimidazole. (DA-A-2) (revenue 27.4 g, yield 40%).
自1H-NMR可知所得化合物為單一異構物(DA-A-2(1N-Boc體))。該異構物之構造係以1H-NMR、13C-NMR及X射線結晶構造解析決定。 The obtained compound was a single isomer (DA-A-2 (1N-Boc)) from 1 H-NMR. The structure of the isomer was determined by 1 H-NMR, 13 C-NMR and X-ray crystal structure analysis.
圖1係實施例中使用之二胺化合物之前驅物的化合物(DA-A-2)之X射線構造解析像。 Fig. 1 is an X-ray structural analysis image of a compound (DA-A-2) which is a precursor of a diamine compound used in the examples.
關於所得化合物(DA-A-2(1N-Boc體))之1H-NMR及13C-NMR之測定數據,以及X射線結晶構造解析之解析數據之一部分示於下。 The measurement data of 1 H-NMR and 13 C-NMR of the obtained compound (DA-A-2 (1N-Boc)) and the analysis data of the X-ray crystal structure analysis are shown below.
(DA-A-2)1H-NMR(CDCl3,δppm):9.21(d,J=2.0Hz,1H,C6H3(NO2)2),9.16(d,J=2.0Hz,1H,C6H3(NO2)2),8.07(s,1H,-N=C(H)-N-),5.39(s,2H,CH2),2.53(s,3H,-C=C(N)CH3),1.64(s,9H,t-Bu)。 (DA-A-2) 1 H-NMR (CDCl 3 , δ ppm): 9.21 (d, J = 2.0 Hz, 1H, C 6 H 3 (NO 2 ) 2 ), 9.16 (d, J = 2.0 Hz, 1H) , C 6 H 3 (NO 2 ) 2 ), 8.07 (s, 1H, -N=C(H)-N-), 5.39 (s, 2H, CH 2 ), 2.53 (s, 3H, -C=C (N) CH 3 ), 1.64 (s, 9H, t-Bu).
(DA-A-2)13C-NMR(CDCl3,δppm):162.5,148.5,147.5,137.4,133.8,133.6,129.6,128.7,122.4,85.9,70.0,27.9,11.0(each s)。 (DA-A-2) 13 C-NMR (CDCl 3 , δ ppm): 162.5, 148.5, 147.5, 137.4, 133.8, 133.6, 129.6, 128.7, 122.4, 85.9, 70.0, 27.9, 11.0 (each s).
構造式:C17H18N4O8 Construction formula: C 17 H 18 N 4 O 8
結晶系:單斜晶系(Monoclinic) Crystalline system: monoclinic system (Monoclinic)
空間群:P21/c Space group: P2 1 /c
晶格狀數:a=8.5079(5)埃b=19.6087(12)埃c=11.3540(8)埃β=92.852(4)° Lattice number: a=8.5079(5) angb=19.6087(12) ang c=11.3540(8) angstrom β=92.852(4)°
Z值:4 Z value: 4
R/WR:0.33/0.11 R/WR: 0.33/0.11
於濃縮上述第2步驟之1N-Boc-4-(3,5-二硝基苯甲醯氧基甲基)-5-甲基咪唑(DA-A-2)之合成中之有機層濾液而得之殘渣中添加乙酸乙酯/己烷(容積比:2/1)之混合溶液(889g),再添加水(363g)攪拌1小時,過濾所得固體。將濾液分液,再於有機層中添加乙酸乙酯/己烷(2/1)之混合溶液(889g)、及水(363g)並攪拌,過濾所得固體。濃縮濾液,於殘渣中添加乙酸乙酯/己烷(1/2)之混合溶液(889g),冷卻至0℃,且攪拌獲得析出物。以乙酸乙酯(50g)洗淨固體2次,並乾燥,獲得3N-Boc-4-(3,5-二硝基苯甲醯氧基甲基)-5-甲基咪唑(DA-C-2)(收量4.3g,收率2%)。 The organic layer filtrate in the synthesis of 1N-Boc-4-(3,5-dinitrobenzylideneoxymethyl)-5-methylimidazole (DA-A-2) in the above second step is concentrated. A mixed solution of ethyl acetate/hexane (volume ratio: 2/1) (889 g) was added to the residue, and water (363 g) was added thereto, and the mixture was stirred for 1 hour, and the obtained solid was filtered. The filtrate was separated, and a mixed solution of ethyl acetate/hexane (2/1) (889 g) and water (363 g) were added to the organic layer and stirred, and the obtained solid was filtered. The filtrate was concentrated, and a mixed solution of ethyl acetate/hexane (1/2) (889 g) was added to the residue, and the mixture was cooled to 0 ° C, and stirred to obtain a precipitate. The solid was washed twice with ethyl acetate (50 g) and dried to give 3N-Boc-4-(3,5-dinitrobenzyloxymethyl)-5-methylimidazole (DA-C- 2) (received 4.3 g, yield 2%).
由1H-NMR可知所得化合物為單一異構物(DA-C-2(3N-Boc體))。該異構物之構造係以1H-NMR、及13C-NMR決定。 The obtained compound was a single isomer (DA-C-2 (3N-Boc)) by 1 H-NMR. The structure of the isomer was determined by 1 H-NMR and 13 C-NMR.
關於所得化合物(DA-C-2(3N-Boc體))之1H-NMR及13C-NMR之測定數據列示於下。 The measurement data of 1 H-NMR and 13 C-NMR of the obtained compound (DA-C-2 (3N-Boc)) are shown below.
(DA-C-2)1H-NMR(CDCl3,δppm):9.22(t,J=2.4Hz,1H,C6H3(NO2)2),9.13(d,J=2.4Hz,2H,C6H3(NO2)2),8.11(s,1H,-N=C(H)-N-),5.64(s,2H,CH2),2.34(s,3H,-C=C(N)CH3),1.64(s,9H,t-Bu)。 (DA-C-2) 1 H-NMR (CDCl 3 , δ ppm): 9.22 (t, J = 2.4 Hz, 1H, C 6 H 3 (NO 2 ) 2 ), 9.13 (d, J = 2.4 Hz, 2H , C 6 H 3 (NO 2 ) 2 ), 8.11 (s, 1H, -N=C(H)-N-), 5.64 (s, 2H, CH 2 ), 2.34 (s, 3H, -C=C (N) CH 3 ), 1.64 (s, 9H, t-Bu).
(DA-C-2)13C-NMR(CDCl3,δppm)162.2,148.6,147.0,142.5,138.7,133.8,129.5,122.4,120.2,86.1,57.5,27.9, 12.7(each s)。 (DA-C-2) 13 C-NMR (CDCl 3 , δ ppm) 162.2, 148.6, 147.0, 142.5, 138.7, 133.8, 129.5, 122.4, 120.2, 86.1, 57.5, 27.9, 12.7 (each s).
使1N-Boc-4-(3,5-二硝基苯甲醯氧基甲基)- 5-甲基咪唑(DA-A-2)(21.9g,53.8mmol)懸浮於甲醇(175g)中,以氮氣置換系內後,添加5質量%之鈀-碳(2.18g,55質量%含水物),以氫氣置換系內,在室溫反應8天。隨後,以HPLC(高速液體層析)確認原料消失,且藉過濾去除鈀-碳。接著,在40℃、120mmHg減壓餾除溶劑甲醇(100g),隨後添加2-丙醇(103g)。再度在40℃、120mmHg下減壓餾除溶劑甲醇及2-丙醇(150g),接著添加2-丙醇(50g)。隨後,在冰冷卻下靜置1小時,析出二胺(DA-A),經過濾、乾燥,獲得芳香族二胺化合物(DA-A)(12.9g,收率69%)。 Making 1N-Boc-4-(3,5-dinitrobenzylideneoxymethyl)- 5-methylimidazole (DA-A-2) (21.9 g, 53.8 mmol) was suspended in methanol (175 g), and after replacing the inside with nitrogen, 5% by mass of palladium-carbon (2.18 g, 55 mass% of water was added) The material was replaced with hydrogen and reacted at room temperature for 8 days. Subsequently, the disappearance of the starting material was confirmed by HPLC (High Speed Liquid Chromatography), and palladium-carbon was removed by filtration. Next, the solvent methanol (100 g) was distilled off under reduced pressure at 40 ° C and 120 mmHg, followed by the addition of 2-propanol (103 g). The solvent methanol and 2-propanol (150 g) were distilled off under reduced pressure at 40 ° C and 120 mmHg, followed by 2-propanol (50 g). Subsequently, it was allowed to stand under ice cooling for 1 hour to precipitate a diamine (DA-A), which was filtered and dried to give an aromatic diamine compound (DA-A) (12.9 g, yield 69%).
1H-NMR(CDCl3,δppm):7.98(s,1H,-N=C(H)-N-),6.68 (d,J=2.0Hz,1H,C6H3(NH2)2),6.06(t,2H,C6H3(NH2)2),5.14(s,2H,CH2),2.42(s,3H,-C=C(N)CH3),1.55(s,9H,t-Bu)。 1 H-NMR (CDCl 3 , δ ppm): 7.98 (s, 1H, -N=C(H)-N-), 6.68 (d, J = 2.0 Hz, 1H, C 6 H 3 (NH 2 ) 2 ) , 6.06 (t, 2H, C 6 H 3 (NH 2 ) 2 ), 5.14 (s, 2H, CH 2 ), 2.42 (s, 3H, -C=C(N)CH 3 ), 1.55 (s, 9H) , t-Bu).
13C-NMR(CDCl3,δppm):166.7,147.5,147.4,136.9,134.8,131.6,127.7,106.7,105.5,85.4,58.9,27.7,10.8(each s)。 13 C-NMR (CDCl 3 , δ ppm): 166.7, 147.5, 147.4, 136.9, 134.8, 131.6, 127.7, 106.7, 105.5, 85.4, 58.9, 27.7, 10.8 (each s).
使3N-Boc-4-(3,5-二硝基苯甲醯氧基甲基)-5-甲基咪唑(DA-C-2)(2.00g,4.92mmol)懸浮於甲醇(16g)中,以氮氣置換系內後,添加5質量%鈀-碳(0.201g,57質量%含水物),以氫氣置換系內,且在室溫反應3天。隨後,以HPLC確認原料消失後,藉過濾去除鈀-碳,使溶劑經濃縮乾固,獲得芳香族二胺化合物(DA-C)(1.43g,收率84%)。 3N-Boc-4-(3,5-dinitrobenzylideneoxymethyl)-5-methylimidazole (DA-C-2) (2.00 g, 4.92 mmol) was suspended in methanol (16 g) After replacing the inside with nitrogen, 5% by mass of palladium-carbon (0.201 g, 57% by mass of hydrate) was added, and the inside was replaced with hydrogen, and reacted at room temperature for 3 days. Subsequently, after confirming the disappearance of the starting material by HPLC, the palladium-carbon was removed by filtration, and the solvent was concentrated to dryness to obtain an aromatic diamine compound (DA-C) (1.43 g, yield: 84%).
1H-NMR(CDCl3,δppm):8.11(s,1H,-N=C(H)-N-),6.73(d,J=2.0Hz,1H,C6H3(NH2)2),6.16(t,J=2.0Hz,2H,C6H3(NH2)2),5.40(s,2H,CH2),2.28(s,3H,-C=C(N)CH3),1.57(s,9H,t-Bu)。 1 H-NMR (CDCl 3 , δ ppm): 8.11 (s, 1H, -N=C(H)-N-), 6.73 (d, J = 2.0 Hz, 1H, C 6 H 3 (NH 2 ) 2 ) , 6.16 (t, J = 2.0 Hz, 2H, C 6 H 3 (NH 2 ) 2 ), 5.40 (s, 2H, CH 2 ), 2.28 (s, 3H, -C=C(N)CH 3 ), 1.57 (s, 9H, t-Bu).
13C-NMR(CDCl3,δppm):166.6,147.5,147.3,141.6,138.5,131.8,121.1,106.8,105.7,85.8,56.0,27.8,12.7(each s)。 13 C-NMR (CDCl 3 , δ ppm): 166.6, 147.5, 147.3, 141.6, 138.5, 131.8, 121.1, 106.8, 105.7, 85.8, 56.0, 27.8, 12.7 (each s).
於附有攪拌裝置及氮氣導入管之50mL四頸燒瓶中放入0.457g(3.00mmol)之3,5-二胺基苯甲酸,添加3.75g之NMP,邊吹送氮氣邊攪拌使之溶解。接著,添加1.039g(3.00mmol)之DA-A、0.801g(4.00mmol)之ODA、及1.87g之GBL,邊吹送氮氣邊攪拌使之溶解。邊攪拌該二胺溶液邊添加0.594g(3.00mmol)之BDA、及3.00g之GBL,在水冷下攪拌2小時。接著,添加1.505g(6.9mmol)之PMDA、及10.12g之GBL,在水冷下攪拌24小時。所得聚醯胺酸溶液在溫度25.0℃之黏度為3010mPa.s。且,該聚醯胺酸之分子量為Mn=17015,Mw=42151。接著,於該溶液中添加4.40g之以NMP/GBL比為2/8(容積比,以下同)之混合溶液稀釋成0.3質量%之3-縮水甘油氧基丙基甲基二乙氧基矽烷溶液,獲得聚醯胺酸溶液。 0.47 g (3.00 mmol) of 3,5-diaminobenzoic acid was placed in a 50 mL four-necked flask equipped with a stirring device and a nitrogen introduction tube, and 3.75 g of NMP was added thereto, and the mixture was stirred and dissolved by blowing nitrogen gas. Next, 1.039 g (3.00 mmol) of DA-A, 0.801 g (4.00 mmol) of ODA, and 1.87 g of GBL were added, and the mixture was stirred and dissolved while blowing nitrogen gas. While stirring the diamine solution, 0.594 g (3.00 mmol) of BDA and 3.00 g of GBL were added, and the mixture was stirred under water cooling for 2 hours. Next, 1.505 g (6.9 mmol) of PMDA and 10.12 g of GBL were added, and the mixture was stirred under water cooling for 24 hours. The obtained polyaminic acid solution has a viscosity of 3010 mPa at a temperature of 25.0 ° C. s. Further, the molecular weight of the polyamic acid was Mn = 17015 and Mw = 42,151. Next, 4.40 g of a mixed solution having a NMP/GBL ratio of 2/8 (volume ratio, the same below) was added to the solution to be diluted to 0.3% by mass of 3-glycidoxypropylmethyldiethoxydecane. Solution to obtain a polyaminic acid solution.
將所得之聚醯胺酸溶液5.63g、0.57g之NMP、9.81g之GBL、及4.0g之BCS添加於加入攪拌子之50mL樣品瓶中,獲得液晶配向劑(A-1)。該液晶配向劑未見到混濁或析出等之以上,確認為均勻溶液。 5.63 g of the obtained polyaminic acid solution, 0.57 g of NMP, 9.81 g of GBL, and 4.0 g of BCS were placed in a 50 mL sample vial to which a stir bar was added to obtain a liquid crystal alignment agent (A-1). The liquid crystal alignment agent was not observed to be turbid or precipitated, and was confirmed to be a homogeneous solution.
於附有攪拌裝置及氮氣導入管之50mL四頸燒瓶中放 入2.355g(6.80mmol)之DA-A及2.02g(10.20mmol)之DDM,添加6.94g之NMP及3.47g之GBL,邊吹送氮氣邊攪拌並使之溶解。邊攪拌該二胺溶液邊添加1.634g(8.33mmol)之CBDA及5.55g之GBL,在水冷下攪拌2小時。接著,添加2.127g(8.50mmol)之BODA及18.7g之GBL,在水冷下攪拌24小時。所得聚醯胺酸溶液在溫度25.0℃之黏度為99.3mPa.s。另外,該聚醯胺酸之分子量為Mn=5245,Mw=9647。接著,於該溶液中添加8.14g之以NMP/GBL比為2/8之混合溶液稀釋成0.3質量%之3-縮水甘油氧基丙基甲基二乙氧基矽烷溶液,獲得聚醯胺酸溶液。 Placed in a 50 mL four-necked flask with a stirring device and a nitrogen inlet tube 2.355 g (6.80 mmol) of DA-A and 2.02 g (10.20 mmol) of DDM were added, and 6.94 g of NMP and 3.47 g of GBL were added, and the mixture was stirred and dissolved while blowing nitrogen gas. While stirring the diamine solution, 1.634 g (8.33 mmol) of CBDA and 5.55 g of GBL were added, and the mixture was stirred under water cooling for 2 hours. Next, 2.127 g (8.50 mmol) of BODA and 18.7 g of GBL were added, and the mixture was stirred under water cooling for 24 hours. The viscosity of the obtained polyaminic acid solution at a temperature of 25.0 ° C is 99.3 mPa. s. Further, the molecular weight of the poly-proline was Mn = 5245 and Mw = 9647. Next, 8.14 g of a mixed solution of NMP/GBL ratio of 2/8 was added to the solution to prepare a 0.3% by mass solution of 3-glycidoxypropylmethyldiethoxydecane to obtain polylysine. Solution.
將所得之聚醯胺酸溶液5.63g、0.57g之NMP、9.81g之GBL及4.0g之BCS添加於加入攪拌子之50mL樣品瓶中,獲得液晶配向劑(A-2)。該液晶配向劑未見到混濁或析出等之以上,確認為均勻溶液。 5.63 g of the obtained polyaminic acid solution, 0.57 g of NMP, 9.81 g of GBL, and 4.0 g of BCS were placed in a 50 mL sample vial to which a stir bar was added to obtain a liquid crystal alignment agent (A-2). The liquid crystal alignment agent was not observed to be turbid or precipitated, and was confirmed to be a homogeneous solution.
於附有攪拌裝置及氮氣導入管之50mL四頸燒瓶中置入0.913g(6.00mmol)之3,5-二胺基苯甲酸,添加6.67g之NMP,邊吹送氮氣邊攪拌使之溶解。接著,添加2.803g(14.0mmol)之ODA及3.34g之GBL,邊吹送氮氣邊攪拌使之溶解。邊攪拌該二胺溶液邊添加1.189g(6.00mmol)之BDA及4.67g之GBL,在水冷下攪拌2小時。接著,添加2.923g(13.4mmol)之PMDA及18.7g 之GBL,在水冷下攪拌24小時。所得聚醯胺酸溶液在溫度25.0℃之黏度為3701mPa.s。且,該聚醯胺酸之分子量為Mn=11194,Mw=26713。接著,於該溶液中添加7.83g之以NMP/GBL比為2/8之混合溶液稀釋成0.3質量%之3-縮水甘油氧基丙基甲基二乙氧基矽烷溶液,獲得聚醯胺酸溶液。 0.93 g (6.00 mmol) of 3,5-diaminobenzoic acid was placed in a 50 mL four-necked flask equipped with a stirring device and a nitrogen introduction tube, and 6.67 g of NMP was added thereto, and the mixture was stirred and dissolved by blowing nitrogen gas. Next, 2.803 g (14.0 mmol) of ODA and 3.34 g of GBL were added, and the mixture was dissolved while stirring with nitrogen gas. While stirring the diamine solution, 1.189 g (6.00 mmol) of BDA and 4.67 g of GBL were added, and the mixture was stirred under water cooling for 2 hours. Next, 2.923 g (13.4 mmol) of PMDA and 18.7 g were added. The GBL was stirred under water cooling for 24 hours. The viscosity of the obtained polyaminic acid solution at a temperature of 25.0 ° C is 3701 mPa. s. Further, the molecular weight of the polyproline was Mn = 11194 and Mw = 26713. Next, 7.83 g of a mixed solution of NMP/GBL ratio of 2/8 was added to the solution to a 0.3% by mass solution of 3-glycidoxypropylmethyldiethoxydecane to obtain polylysine. Solution.
將所得之聚醯胺酸溶液5.63g、0.57g之NMP、9.81g之GBL及4.0g之BCS添加於加入攪拌子之50mL樣品瓶中,獲得液晶配向劑(B-1)。該液晶配向劑未見到混濁或析出等之以上,確認為均勻溶液。 5.63 g of the obtained polyaminic acid solution, 0.57 g of NMP, 9.81 g of GBL, and 4.0 g of BCS were added to a 50 mL sample vial to which a stir bar was added to obtain a liquid crystal alignment agent (B-1). The liquid crystal alignment agent was not observed to be turbid or precipitated, and was confirmed to be a homogeneous solution.
於附有攪拌裝置及氮氣導入管之50mL四頸燒瓶中置入0.457g(3.00mmol)之3,5-二胺基苯甲酸,添加3.53g之NMP,邊吹送氮氣邊攪拌使之溶解。接著,添加0.778g(3.00mmol)之DA-B、0.801g(4.00mmol)之ODA及1.76g之GBL,邊吹送氮氣邊攪拌使之溶解。邊攪拌該二胺溶液邊添加0.594g(3.00mmol)之BDA及2.82g之GBL,在水冷下攪拌2小時。接著,添加1.505g(6.9mmol)之PMDA及9.52g之GBL,在水冷下攪拌24小時。然而,反應過程中引起聚合物析出,無法調製液晶配向劑。 0.47 g (3.00 mmol) of 3,5-diaminobenzoic acid was placed in a 50 mL four-necked flask equipped with a stirring device and a nitrogen introduction tube, and 3.53 g of NMP was added thereto, and the mixture was stirred and dissolved by blowing nitrogen gas. Next, 0.778 g (3.00 mmol) of DA-B, 0.801 g (4.00 mmol) of ODA, and 1.76 g of GBL were added, and the mixture was stirred and dissolved by blowing nitrogen gas. While stirring the diamine solution, 0.594 g (3.00 mmol) of BDA and 2.82 g of GBL were added, and the mixture was stirred under water cooling for 2 hours. Next, 1.505 g (6.9 mmol) of PMDA and 9.52 g of GBL were added, and the mixture was stirred under water cooling for 24 hours. However, the polymer was precipitated during the reaction, and the liquid crystal alignment agent could not be prepared.
於附有攪拌裝置及氮氣導入管之50mL四頸燒瓶中置入3.965g(20.0mmol)之DDM,添加7.15g之NMP及3.58g之GBL,邊吹送氮氣邊攪拌使之溶解。邊攪拌該二胺溶液邊添加1.922g(9.80mmol)之CBDA及5.72g之GBL,在水冷下攪拌2小時。接著,添加2.502g(10.00mmol)之BODA及12.2g之GBL,在水冷下攪拌24小時。所得聚醯胺酸溶液在溫度25.0℃之黏度為1534mPa.s。且,該聚醯胺酸之分子量為Mn=13910,Mw=41256。接著,於該溶液中添加8.39g之以NMP/GBL比為2/8之混合溶液稀釋成0.3質量%之3-縮水甘油氧基丙基甲基二乙氧基矽烷溶液,獲得聚醯胺酸溶液。 3.965 g (20.0 mmol) of DDM was placed in a 50 mL four-necked flask equipped with a stirring device and a nitrogen introduction tube, and 7.15 g of NMP and 3.58 g of GBL were added, and the mixture was dissolved while stirring with nitrogen gas. While stirring the diamine solution, 1.922 g (9.80 mmol) of CBDA and 5.72 g of GBL were added, and the mixture was stirred under water cooling for 2 hours. Next, 2.502 g (10.00 mmol) of BODA and 12.2 g of GBL were added, and the mixture was stirred under water cooling for 24 hours. The obtained polyaminic acid solution has a viscosity of 1534 mPa at a temperature of 25.0 ° C. s. Further, the molecular weight of the polyamic acid was Mn = 13910 and Mw = 41256. Next, 8.39 g of a mixed solution of NMP/GBL ratio of 2/8 was added to the solution to a 0.3% by mass solution of 3-glycidoxypropylmethyldiethoxysilane to obtain polylysine. Solution.
將所得聚醯胺酸溶液5.63g、0.57g之NMP、9.81g之GBL及4.0g之BCS添加於加入攪拌子之50mL樣品瓶中,獲得液晶配向劑(B-2)。該液晶配向劑未見到混濁或析出等之以上,確認為均勻溶液。 5.63 g of the obtained polyaminic acid solution, 0.57 g of NMP, 9.81 g of GBL, and 4.0 g of BCS were added to a 50 mL sample vial to which a stir bar was added to obtain a liquid crystal alignment agent (B-2). The liquid crystal alignment agent was not observed to be turbid or precipitated, and was confirmed to be a homogeneous solution.
於附有攪拌裝置及氮氣導入管之50mL四頸燒瓶中置入1.76g(6.80mmol)之DA-B及2.02g(10.20mmol)之DDM,添加6.43g之NMP及3.22g之GBL,邊吹送氮氣邊攪拌使之溶解。邊攪拌該二胺溶液邊添加1.634g(8.33mmol)之CBDA及5.15g之GBL,在水冷下攪拌2小時。接著,添加2.127g(8.50mmol)之BODA及17.3g之GBL,在水冷下攪拌24小時。然而,反應過程中引起 聚合物之析出,無法獲得聚醯胺酸溶液,無法調製液晶配向劑。 1.76 g (6.80 mmol) of DA-B and 2.02 g (10.20 mmol) of DDM were placed in a 50 mL four-necked flask equipped with a stirring device and a nitrogen introduction tube, and 6.43 g of NMP and 3.22 g of GBL were added while blowing. The nitrogen gas was stirred to dissolve it. While stirring the diamine solution, 1.634 g (8.33 mmol) of CBDA and 5.15 g of GBL were added, and the mixture was stirred under water cooling for 2 hours. Next, 2.127 g (8.50 mmol) of BODA and 17.3 g of GBL were added, and the mixture was stirred under water cooling for 24 hours. However, caused during the reaction When the polymer was precipitated, the polyaminic acid solution could not be obtained, and the liquid crystal alignment agent could not be prepared.
使用實施例及比較例所得之液晶配向劑,以0.2μm之過濾器過濾後,旋轉塗佈於附有ITO透明電極之玻璃基板上。隨後,在80℃之加熱板上乾燥2分鐘,在230℃燒成20分鐘,形成膜厚100nm之塗膜。透過遮罩將鋁蒸鍍於該塗膜表面,形成1.0mm之上部電極(鋁電極),作為體積電阻率測定用試料。在該試料之ITO電極與鋁電極之間施加1V之直流電壓,測定自施加電壓開始180秒後之電流值,由該值與電極面積、膜厚算出體積電阻率。 Using the liquid crystal alignment agent obtained in the examples and the comparative examples, the mixture was filtered through a 0.2 μm filter and then spin-coated on a glass substrate with an ITO transparent electrode. Subsequently, it was dried on a hot plate at 80 ° C for 2 minutes and baked at 230 ° C for 20 minutes to form a coating film having a film thickness of 100 nm. Alvaporating aluminum on the surface of the coating film through a mask to form 1.0 mm The upper electrode (aluminum electrode) was used as a sample for volume resistivity measurement. A DC voltage of 1 V was applied between the ITO electrode and the aluminum electrode of the sample, and the current value after 180 seconds from the application of the voltage was measured, and the volume resistivity was calculated from the value and the electrode area and the film thickness.
測定結果彙整示於表1。 The measurement results are shown in Table 1.
以0.2μm之過濾器過濾實施例及比較例所得之液晶配向劑後,旋轉塗佈於形成有具有以分別具有梳型齒狀之形狀、且彼此之梳型齒部分分開並咬入之方式配置之一對ITO電極(電極寬:10μm,電極間隔:10μm,電極高度:50nm)之平面切換(In Plain Switching:以下稱為IPS)驅動用電極作為電極的玻璃基板上。隨後,在80℃之加熱板上乾燥2分鐘,在230℃燒成20分鐘,獲得膜厚 100nm之塗膜。以縲縈布摩擦(輥徑120mm,轉數1000rpm,移動速度20mm/sec,壓入量0.3mm,相對於IPS梳型齒電極成15度之角度)該聚醯亞胺膜。隨後,在純水中進行1分鐘之超音波洗淨,在80℃乾燥10分鐘,獲得附有液晶配向膜之基板。且,對作為對向基板之未形成電極之具有高4μm之柱狀隔離材之玻璃基板亦同樣形成塗膜,且同樣施以配向處理。 The liquid crystal alignment agent obtained in the examples and the comparative examples was filtered through a 0.2 μm filter, and then spin-coated to be formed so as to have a comb-shaped tooth shape and separate and bite each other. One of the pair of ITO electrodes (electrode width: 10 μm, electrode spacing: 10 μm, electrode height: 50 nm) was switched on a glass substrate (In Plain Switching: hereinafter referred to as IPS) as an electrode. Subsequently, it was dried on a hot plate at 80 ° C for 2 minutes and baked at 230 ° C for 20 minutes to obtain a film thickness. 100 nm coating film. The polyimide film was rubbed with a crepe cloth (roller diameter: 120 mm, number of revolutions of 1000 rpm, moving speed of 20 mm/sec, press-in amount of 0.3 mm, and angle of 15 degrees with respect to the IPS comb-type tooth electrode). Subsequently, ultrasonic cleaning was performed for 1 minute in pure water, and dried at 80 ° C for 10 minutes to obtain a substrate with a liquid crystal alignment film. Further, a coating film was formed in the same manner as the glass substrate having a columnar spacer having a height of 4 μm as an electrode on the opposite substrate, and the alignment treatment was also applied.
如上述,以2片基板為一組,於一基板上印刷密封劑,以使2片基板之摩擦方向成180度反方向之方式貼合後,使密封劑硬化製作空胞。以減壓注入法將液晶MLC-2041(Merck公司製造)注入該空胞中,且密封注入口,獲得IPS模式液晶胞。 As described above, the sealant is printed on one of the two substrates, and the sealant is bonded so that the rubbing directions of the two substrates are 180 degrees in the opposite direction, and the sealant is hardened to form a hollow cell. Liquid crystal MLC-2041 (manufactured by Merck Co., Ltd.) was injected into the hollow cell by a vacuum injection method, and the injection port was sealed to obtain an IPS mode liquid crystal cell.
使用實施例4中製作之各液晶胞(IPS模式液晶胞),利用東陽技術公司製造之6254型液晶物性評估裝置進行測定。在60℃之溫度下對各液晶胞施加4V之電壓60μ秒,測定自解除施加後1667m秒後之電壓保持率((自解除施加後1667m秒後之電壓)/剛施加之電壓)×100%)。 The measurement was carried out by using the liquid crystal cell (IPS mode liquid crystal cell) produced in Example 4 using a 6254 liquid crystal physical property evaluation device manufactured by Dongyang Technology Co., Ltd. A voltage of 4 V was applied to each liquid crystal cell at a temperature of 60 ° C for 60 μsec, and the voltage holding ratio after 1667 m seconds after the application was released ((voltage after 1667 m seconds after the application was released) / voltage just applied) × 100% ).
測定結果彙整示於表1。 The measurement results are shown in Table 1.
將實施例4中製作之各液晶胞(IPS模式液晶胞)置於光源上,測定V-T特性(電壓-透過率特性)後,施加使透過率成為23%之交流電壓/60Hz之矩形波10分鐘。接著,對於23.0%交流電壓/60Hz矩形波重疊直流1V並驅動30分鐘。隨後,切斷直流電壓,再僅以23%之交流電壓/60Hz矩形波驅動30秒,隨後測定液晶胞之透過率。評估所得透過率與初期透過率(23.0%)之差(△T(%))作為液晶顯示元件內源自因直流電壓所致之殘留電荷之殘像。 Each liquid crystal cell (IPS mode liquid crystal cell) produced in Example 4 was placed on a light source, and VT characteristics (voltage-transmittance characteristics) were measured, and then an alternating current voltage of 60% transmittance/60 Hz rectangular wave was applied for 10 minutes. . Next, a DC of 1 V was superimposed on a rectangular wave of 23.0% ac/60 Hz and driven for 30 minutes. Subsequently, the DC voltage was cut off, and then driven by a 23% AC voltage/60 Hz rectangular wave for 30 seconds, and then the transmittance of the liquid crystal cell was measured. The difference (ΔT (%)) between the obtained transmittance and the initial transmittance (23.0%) was evaluated as a residual image derived from the residual electric charge due to the DC voltage in the liquid crystal display element.
評價結果彙整示於表1。 The summary of the evaluation results is shown in Table 1.
由表1之結果可知,本發明實施例之聚合物之溶解性優異。另外,由實施例之液晶配向劑所得之液晶配向膜相較於由比較例之液晶配向劑所得之液晶配向膜,具有較低之體積電阻率。亦即,實施例之化合物可形成溶解性 優異之聚合物,且液晶配向劑之調製容易,可形成具有低體積電阻率之液晶配向膜。 From the results of Table 1, it is understood that the polymer of the examples of the present invention is excellent in solubility. Further, the liquid crystal alignment film obtained from the liquid crystal alignment agent of the example had a lower volume resistivity than the liquid crystal alignment film obtained from the liquid crystal alignment agent of the comparative example. That is, the compounds of the examples can form solubility The polymer is excellent, and the liquid crystal alignment agent is easily prepared, and a liquid crystal alignment film having a low volume resistivity can be formed.
另外,可知具有實施例之液晶配向膜之液晶胞具有優異之殘像特性與高的電壓保持率,且具有液晶顯示元件所要求之性能。 Further, it is understood that the liquid crystal cell having the liquid crystal alignment film of the example has excellent afterimage characteristics and a high voltage holding ratio, and has performance required for a liquid crystal display element.
藉由使用含有本發明聚合物之液晶配向劑,可獲得電特性優異、殘像等顯示不良經改善之液晶配向膜,且該液晶配向膜可利用於過去以來要求高的顯示品質之大型液晶電視,或者近年來急速要求顯示品質提升之智慧型手機或平板型電腦等之液晶顯示元件中。 By using a liquid crystal alignment agent containing the polymer of the present invention, a liquid crystal alignment film having excellent electrical characteristics and improved display defects such as afterimages can be obtained, and the liquid crystal alignment film can be utilized for a large-sized liquid crystal television having high display quality in the past. Or in the liquid crystal display elements such as smart phones or tablet computers that are rapidly demanding display quality improvement in recent years.
又,2012年8月29日提出申請之日本專利申請案2012-188874號之說明書、申請專利範圍、圖式及摘要之全部內容援用於本文,且作為本發明說明書之揭示納入本文中。 The entire contents of the specification, the scope of the application, the drawings and the abstract of the Japanese Patent Application No. 2012-188874, filed on Aug.
Claims (13)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012188874 | 2012-08-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201431954A TW201431954A (en) | 2014-08-16 |
| TWI605091B true TWI605091B (en) | 2017-11-11 |
Family
ID=50183595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102131039A TWI605091B (en) | 2012-08-29 | 2013-08-29 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP6233309B2 (en) |
| KR (1) | KR102125106B1 (en) |
| CN (1) | CN104756001B (en) |
| TW (1) | TWI605091B (en) |
| WO (1) | WO2014034790A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11912827B2 (en) | 2019-10-29 | 2024-02-27 | Daxin Materials Corporation | Poly(imide-ester-amide) copolymer and optical film |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6631077B2 (en) * | 2014-11-05 | 2020-01-15 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device |
| JP6447304B2 (en) * | 2015-03-27 | 2019-01-09 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and manufacturing method thereof, liquid crystal display element, retardation film and manufacturing method thereof, polymer and compound |
| WO2017061575A1 (en) * | 2015-10-07 | 2017-04-13 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| KR101989587B1 (en) | 2016-03-28 | 2019-06-14 | 주식회사 엘지화학 | Liquid crystal photoalignment agent, liquid crystal photoalignment film containing the same and method for preparing liquid crystal photoalignment film |
| TWI687457B (en) * | 2016-08-24 | 2020-03-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent and use thereof |
| JP7089228B2 (en) * | 2016-09-29 | 2022-06-22 | 日産化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
| KR102453433B1 (en) * | 2016-09-29 | 2022-10-11 | 닛산 가가쿠 가부시키가이샤 | A liquid crystal aligning agent, a liquid crystal aligning film, and a liquid crystal display element |
| CN110462501B (en) * | 2016-12-28 | 2022-10-28 | 日产化学株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
| JP7078033B2 (en) | 2017-03-22 | 2022-05-31 | 日産化学株式会社 | Polymer and liquid crystal alignment agent using it |
| WO2018211697A1 (en) | 2017-05-19 | 2018-11-22 | ヤマハ株式会社 | Sound processing device and control method of sound processing device |
| CN108383733B (en) * | 2018-01-15 | 2020-11-24 | 上海交通大学 | Diamine monomer containing tert-butyl and aliphatic ring and its preparation and application |
| CN112457867B (en) * | 2020-12-15 | 2021-08-03 | 深圳清荷科技有限公司 | Liquid crystal film material, liquid crystal alignment agent, liquid crystal alignment film and preparation method thereof, and liquid crystal display element |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4085206B2 (en) * | 1996-02-15 | 2008-05-14 | 日産化学工業株式会社 | Diaminobenzene derivative, polyimide and liquid crystal alignment film using the same |
| JP3613421B2 (en) | 1996-05-31 | 2005-01-26 | Jsr株式会社 | Liquid crystal alignment agent |
| JP3650982B2 (en) | 1996-10-02 | 2005-05-25 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
| TWI291065B (en) * | 2000-12-26 | 2007-12-11 | Nissan Chemical Ind Ltd | Diamines, polyimide precursors and polyimides produced by using the diamines, and liquid crystal aligning agents |
| CN101100513B (en) * | 2003-06-17 | 2013-04-17 | 日产化学工业株式会社 | Polyimide precursor |
| WO2010050523A1 (en) * | 2008-10-29 | 2010-05-06 | 日産化学工業株式会社 | Diamine, polyimide, liquid crystal aligning agent, and liquid crystal alignment film |
| KR101726456B1 (en) * | 2009-03-10 | 2017-04-12 | 닛산 가가쿠 고교 가부시키 가이샤 | Polyimide precursor, polyimide, and liquid-crystal alignment material |
| CN102893209B (en) * | 2010-03-15 | 2015-05-06 | 日产化学工业株式会社 | Liquid crystal aligning agent and liquid crystal aligning film containing polyamic acid ester |
-
2013
- 2013-08-29 KR KR1020157007457A patent/KR102125106B1/en active Active
- 2013-08-29 WO PCT/JP2013/073173 patent/WO2014034790A1/en not_active Ceased
- 2013-08-29 JP JP2014533084A patent/JP6233309B2/en active Active
- 2013-08-29 TW TW102131039A patent/TWI605091B/en active
- 2013-08-29 CN CN201380055734.3A patent/CN104756001B/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11912827B2 (en) | 2019-10-29 | 2024-02-27 | Daxin Materials Corporation | Poly(imide-ester-amide) copolymer and optical film |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201431954A (en) | 2014-08-16 |
| KR20150052111A (en) | 2015-05-13 |
| WO2014034790A1 (en) | 2014-03-06 |
| KR102125106B1 (en) | 2020-06-19 |
| JP6233309B2 (en) | 2017-11-22 |
| JPWO2014034790A1 (en) | 2016-08-08 |
| CN104756001A (en) | 2015-07-01 |
| CN104756001B (en) | 2017-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI605091B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| KR101688687B1 (en) | Liquid crystal aligning agent | |
| TWI438226B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| KR101986398B1 (en) | Liquid crystal aligning agent, liquid crystal alignment membrane, liquid crystal display element, and method for manufacturing liquid crystal display element | |
| CN103080152B (en) | The manufacture method of liquid crystal aligning agent, liquid crystal orientation film, liquid crystal display device and liquid crystal display device | |
| TWI520948B (en) | A liquid crystal alignment device, a liquid crystal alignment device, a liquid crystal display device, and a liquid crystal display device, and a polymerizable compound | |
| TWI477478B (en) | Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
| JP5975227B2 (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and method for manufacturing liquid crystal display element | |
| TWI464196B (en) | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display device and liquid crystal display device, and polymerizable compound | |
| JP6361898B6 (en) | Polymerizable compound | |
| KR101991140B1 (en) | Method for producing liquid crystal alignment film, liquid crystal alignment film, and liquid crystal display element | |
| KR20170010899A (en) | Diamine compound, liquid crystal aligning agent, and liquid crystal display device using the same | |
| WO2012147939A1 (en) | Polyimide precursor modified with dicarboxylic acid anhydride, and imidized polyimide and liquid crystal alignment treatment agent comprising same | |
| KR20170109604A (en) | Liquid crystal orienting agent, liquid crystal display element, and method for producing liquid crystal display element | |
| WO2013099804A1 (en) | Liquid crystal orientation agent, liquid crystal orientation membrane, liquid crystal display element, and diamine compound | |
| TWI657297B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| CN115521793A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
| TWI683857B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
| KR20170066495A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element using same | |
| WO2016140302A1 (en) | Polyimide precursor, and liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having precursor | |
| TW201402654A (en) | Polymer, liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, and diamine |